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Abstract 
 For tablets made by roller compaction the relationships between formulation 
composition, manufacturing conditions and in-vitro performance were examined. 
Two filler materials with different characteristics were studied. During tablet 
production, two main stresses are experienced by a material. The first stress occurs 
during granulation and the second stress during tableting. These stresses were 
investigated in terms of the tablet properties and disintegration behaviour. Roller 
compaction granulation, a continuous dry granulation process, was used to produce 
granules. The granules were then compacted using varying tableting stresses.  
The tablets were characterised by their porosity and tensile strength (i.e. 
compactibility), and were also examined using X-ray to determine the internal tablet 
structure. The tablet internal structure indicated that the final tablet compactibility 
was dependent on the RC stress used, which governs the consequent granular 
properties. The granular material is then affected by the tableting stress used 
depending on the granular properties and the magnitude of the stress. The tableting 
stress was found to crush and bond the granular material differently, depending on 
the how compacted the granular material is.  
Two different particle imaging methods, as well as the standard USP method, 
were employed to determine which method was most capable of distinguishing the 
effects of processing condition variation on tablet disintegration performance. The 
methods were evaluated to determine their effectiveness at monitoring 
disintegration and the information which is able to be gained from them. By using 
imaging methods to examine tablet disintegration, quantifiable information 
regarding the processes which occur during disintegration was observed, including 
the particle release and change in tablet area with time. It was found that the 
tableting stress has a greater influence on the tablet disintegration than roller 
compaction stress. 
 The findings in this research add to a better understanding of tablet 
behaviour during disintegration due to variation in the formulation and processing 
conditions. This could lead to more knowledge-based approach to the innovation of 
future tablet formulations. 
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Glossary 
API Active Pharmaceutical Ingredient. 
BINDER A liquid or solid component in a tableting formulation which 
binds the other components together during compaction. 
COMPACTIBILITY The relationship between the tensile strength and porosity of a 
compact. 
COMPRESSIBILITY The change in a compact’s tensile strength due to the applied 
compaction pressure. 
DENSITY A measure of mass per volume. 
DISINTEGRANT An excipient that is added to a tablet formulation to promote 
the break-up of the tablet into smaller fragments. 
DISINTEGRATION The break-up of the tablet into smaller fragments with a larger 
surface area. 
DISSOLUTION A solute (i.e. tablet API) dissolving into a solvent (i.e. liquid 
such as water or stomach acid). 
EXCIPIENT A component which is the vehicle or medium for the API, 
which serves a specific purpose (e.g. bulking, binding, aiding 
disintegration/dissolution). 
FILLER An excipient which adds bulk to the tablet formulation to ease 
ingestion by the consumer. 
GRANULE A small compact of powder produced either through 
application of stress or through agglomeration. 
FORMULATION A mixture prepared according to a certain formula. 
PLACEBO A substance which contains no API and therefore has no 
therapeutic value, which can function as a control. 
Introduction 
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LOSS IN 
REWORKABILITY 
A reduction in the ability of a material to plastically deform 
due to the material being “worked” multiple times. 
LUBRICANT An excipient which reduces friction, and therefore sticking of 
the formulation material to the production machinery. 
POROSITY A measure of the void space in a material as a percentage. 
RIBBON A compact produced by application of stress between two 
rollers during roller compaction granulation. A precursor to 
granules. 
TABLET A solid unit dosage produced by application of stress to 
powder or granular material, which may contain a formulation 
or singular material. 
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Chapter 1. Introduction 
1.1 Roller Compaction Granulation 
Granulation is a widely used technique for the conversion of primary powder 
particles into larger, agglomerated granules. Granules are preferred rather than 
powders in the pharmaceutical industry, due to the improvement in bulk granule 
properties such as flowability, wettability, bulk density and homogeneity of the 
components within the formulation. Additionally, granulated material is easier to 
transport and handle as the percentage of fine particles is reduced. This is beneficial, 
for example, when using active pharmaceutical ingredients (API) which are toxic 
when inhaled.  
Various methods can be used to granulate powders, each with their own 
advantages. The granules produced will have different properties, such as size, size 
distribution, strength, porosity and dissolution, depending on the granulation 
technique used. Generally the techniques are characterised as either wet or dry 
granulation. This research focuses on roller compactor dry granulation. 
Dry granulation relies on using an applied stress to densify and bond primary 
particle powders together into a denser compact also known as a ribbon. Roller 
compaction is a predominant dry granulation technique used in the pharmaceutical 
industry as it allows for continuous granulation. This means that a more uniform 
final granule product can be obtained in a continuous line with the elimination of 
the possibility of batch variation (Kleinebudde, 2004). Additionally, roller 
compaction allows for the granulation of materials which are water or temperature 
Introduction 
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sensitive, which may be beneficial when granulating certain API. There is no need 
to use a liquid binder and therefore, the drying step is also eliminated meaning that 
the cost is lowered (Guigon et al., 2007). A downside to roller compaction is that a 
high percentage of fines, i.e. un-compacted powder, may be produced during 
granulation. 
Roller compactor designs vary depending on the manufacturer. Commercially 
available roller compactors may have rollers which are mounted in a vertical, 
inclined or horizontal setting, where the former relies on gravity for the feeding of 
powder and the latter two rely on a feed auger to convey the powder between the 
rollers (Guigon et al., 2007).  
Roller compaction offers the ability to control various processing parameters 
during granulation. These can include screw feed rate, roller speed and crusher 
speed, mesh screen size. The main parameter which can be altered during roller 
compaction is the stress applied to the material when it is between the rollers. It is 
possible to control the thickness of the ribbon and the size, strength and porosity of 
the granules produced via variation of these process parameters (Perez-Gandarillas 
et al., 2015, Kazemi et al., 2017, Pérez Gago et al., 2017). This is beneficial in 
pharmaceutical formulation development as it offers a level of control over the final 
tablet properties.  
While roller compaction is a preferred technique for the production of 
granules, there are inherent issues that can occur. Loss in compressibility of 
granules due to application of stress is a major issue which is observed in roller 
compaction. A higher pressure leads to better compacted ribbons and granules, 
however the consequent tablets exhibit a lower tensile strength (Farber et al., 2008). 
However, with the application of a lower stress leads to an increase in the 
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percentage of uncompacted powder material, otherwise known as fines 
(Inghelbrecht et al., 1997). If a high percentage of fines are obtained then the 
material may need to be re-compacted, which adds additional cost and time to the 
granulation process and, again, a loss in material compressibility (Inghelbrecht and 
Remon, 1998a, Bultmann, 2002).  Therefore, there is a trade-off between the 
ribbon/granule quality and the tablet quality which must be considered. 
1.2 Tableting 
Tablets are the predominant solid dosage forms used in the pharmaceutical 
industry as they allow for precise administration of a drug load with little variation 
between batches. Tablets also have the benefit of being able to withstand 
transportation and storage following production (Cooper and Rees, 1972). 
To produce a tablet, material is subjected to a second stress which compresses 
it into a “slug”. In the pharmaceutical industry, production of a tablet can be carried 
out in one of two ways. The powder mixture can be directly compressed or it can be 
granulated and then the granules are compressed into tablets. The process which is 
used is dependent on the properties of the powder mixture. The powder mixture 
must be free-flowing and not prone to segregation to be suitable for direct 
compression. However, as outlined previously, granulation offers improvement of 
these properties, and additionally reduces the percentage of fines. 
1.3 Tablet Disintegration and Dissolution 
In the pharmaceutical industry, dissolution and disintegration are essential 
tablet properties which are tested when a new tablet formulation is hypothesised. 
Firstly, the breakage of larger agglomerates into smaller particles is termed as tablet 
disintegration (see Figure 1.1). The definition of tablet dissolution can be described 
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as the solid soluble components dissolving into solution (see Figure 1.2). Dissolution 
of the soluble component occurs from the surface of the tablet, therefore 
disintegration aids the dissolution process by providing a larger surface area 
(Fassihi, 1986). 
Figure 1.1 Schematic of tablet disintegration showing the breakage of agglomerates 
released from a tablet. 
Figure 1.2 Schematic of tablet dissolution showing the particles from a tablet dissolving 
into solution. 
The various processes, such as wicking, wetting and penetration, occurring 
during dissolution and disintegration occur in simultaneously to perpetuate the 
break-up of the tablet and release the soluble material (Caramella et al., 1988, 
Lowenthal, 1972, Delalonde and Ruiz, 2008). Furthermore, pharmaceutical tablets 
can contain numerous excipients, each of which behave differently in solution, for 
example hydrophobic or hygroscopic powders (Wan and Prasad, 1988). It has also 
been found that process parameters used to produce the tablet can also affect the 
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dissolution-disintegration behaviour (Merkku et al., 1994). During analysis the 
tablet is analysed as a whole entity, and little knowledge is gained as to how each 
excipient alters the tablet dissolution-disintegration profile.  
In the pharmaceutical industry tablet dissolution and disintegration tests are 
carried out at first in vitro as an important initial indicator of the probable tablet 
performance in vivo. A standard dissolution-disintegration testing apparatus is used 
to determine whether a tablet performs suitably (Donauer and Löbenberg, 2007). A 
commonly used dissolution apparatus is the USP II (Figure 1.3), which comprises a 
vessel containing a paddle which agitates the solution, a mesh basket for the 
placement of the tablet, and a probe (e.g. conductivity or UV) capable of measuring 
the concentration of the soluble material in solution (Azarmi et al., 2007). 
Figure 1.3 Image of a USP II apparatus with 8 vessels. 
Tablet dissolution is measured by the time taken for the concentration of the 
relevant soluble material to reach a set end point, e.g. for a fast-release tablet 90 % 
API concentration in 30 min would be expected. Disintegration is simply measured 
by the time taken for a tablet to fully pass through the mesh basket. Tablets must 
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conform to the standards set by the appropriate governing body (Williams, 2006). 
The data is analysed and if the tablet does not perform as expected then the tablet 
formulation is re-examined and the tablet formulation is altered in an attempt to 
manipulate the tablet to behave as required. This cycle may occur repeatedly until 
an ideal formulation is reached which can go on to the next testing stage of 
formulation development. However this “data-driven”, pass or fail approach does 
not provide any knowledge as to why the tablet failed. An additional problem with 
standard testing is that disintegration and dissolution tests are separate and are not 
related to each other. The dissolution is measured with time, whereas the 
disintegration is a singular time point following complete tablet disintegration. 
Additionally, tablet formulations generally have more than one soluble component 
and conductivity and UV may not be able to differentiate between them. Therefore, 
generally the dissolution measurement is only an indication of the concentration of 
the API in solution. 
1.4 Aims and Objectives 
This research aims to analyse the effects of varying the formulation and two 
fundamental stresses which are applied to a material during the process of 
producing a tablet via roller compaction granulation.  
For this research a brittle material and a ductile material have been chosen so 
that these properties may be examined. The effects of varying the two processing 
stresses will be determined in terms of the tablet compactibility, i.e. the tensile 
strength and porosity. Additionally, X-ray tomography will be utilised to examine 
the ribbons and tablets produced. This will also allow for examination of the tablet 
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internal structure and to relate this to the “loss in compressibility” of tablets, and 
consequently the tablet disintegration behaviour. 
The tablet disintegration behaviour will be examined using 3 different 
methods; the standard USP method, the Flow Cell imaging method and the off-line 
LIXELL particle imaging method. The dissolution behaviour will also be evaluated 
off-line using 1H NMR spectroscopy. 
The LIXELL imaging method, used in conjunction with the NMR method, is a 
measurement technique which is able to monitor the particle release and dissolution 
with time. The Flow Cell disintegration analysis method is capable of visualising the 
change in tablet area and the particle release in real-time.  
1.5 Thesis Layout 
In Chapters 1 and 2 a background in roller compaction granulation and tablet 
disintegration have been outlined. Literature has been examined to exhibit the 
current understanding of the effects of granulation and other factors which affect 
tablet disintegrations. Alternative methods to analyse tablet disintegration have also 
been evaluated. 
In Chapter 3 the characterisation of the roller compacted material has been 
presented. This includes the characterisation of the ribbons, granules and tablets 
produced using varying roller compaction pressures and tableting forces. The tablet 
compactibility and the phenomenon of “loss in compressibility” will be examined 
depending on the granulation and tableting stresses used. The internal structure of 
tablets will be analysed. 
Chapter 4 explores the use of a modified USP apparatus connected to a 
LIXELL particle imaging method to analyse tablet disintegration. The effect of 
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varying RC pressure and tableting force was examined and linked to the findings in 
the previous chapters. 1H NMR was used to determine the dissolution behaviour of 
mannitol. 
In Chapter 5 the Flow Cell method was examined in depth to determine the 
effect of varying the stresses applied during roller compaction and tableting. The 
effects were observed in terms of the change in tablet area and the particle release.  
In Chapter 6 a study was carried out to compare the capabilities of the Flow 
Cell method and the standard USP method. It was examined whether the Flow Cell 
method was able to elucidate additional information regarding the processes which 
occur during tablet disintegration. It was also examined whether the Flow Cell 
method was capable of detecting the changes in tablet disintegration when the 
processing parameters were varied.  
Chapter 8 concludes the research and outlines the main findings. The tablet 
compactibility was clarified in terms of the stresses applied during RC and 
tableting. The tablet disintegration behaviour observed using the LIXELL, the Flow 
Cell method and USP method was related to the tablet properties. The dissolution 
trends were also examined. 
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Chapter 2. Literature 
Review  
2.1 Introduction 
Understanding the mechanisms occurring during the disintegration of tablets 
is vital, particularly in the pharmaceutical industry due to the precision required 
when administering drug loads. Quality by design (QbD) within the pharmaceutical 
industry requires that the preparation of solid dosage tablets must be carried out 
within strict and well-planned conditions so that the tablet releases the active 
pharmaceutical ingredient (API) in a precise manner when ingested (Azarmi et al., 
2007). Variation in the materials within the formulation and the processing 
parameters, i.e. during granulation or tableting, affects the disintegration behaviour. 
Understanding the link between each variation and the effect on the tablet 
disintegration could lead to more proficient tablet design. Additionally, by using 
novel techniques the disintegration process itself can be understood in more depth.  
This Chapter will review the current research and understanding surrounding 
the effects of variation of the tablet formulation, roller compaction parameters and 
tableting parameters on tablets, and consequently tablet disintegration and 
dissolution. A focus will be put on the phenomenon of “loss in compressibility” in 
tablets following roller compaction and tableting to determine the current 
understanding.  
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It will also cover the alternative techniques currently being developed in 
research which analyse tablet disintegration and what information is available to be 
gained by them. This research focuses on placebo formulations and therefore 
research concerning APIs is beyond the scope of this work. 
2.2 Factors Affecting Disintegration and 
Dissolution 
2.2.1 Pharmaceutical Tablet Formulation 
Pharmaceutical solid dosage systems consist of various excipients which each 
play a role in the disintegration and dissolution tablet. Table 2.1 shows the different 
excipient components which are commonly used in pharmaceutical tablet 
formulations. Generally a solid dosage tablet will contain an API and additional 
pharmacologically inert excipient materials, depending on the functionality of the 
tablet (Pifferi et al., 1999). The most important factor that must be considered is the 
efficient transport of the API from the solid tablet into the solute. To enable the 
precise dissolution of API, the remaining inert excipients each play important roles 
in aiding its precise release. Some APIs are poorly soluble and therefore the 
formulation would require carefully selected excipients which promote 
disintegration and dissolution so that the function of the API is able to be carried 
out (Buggins et al., 2007, Desai et al., 1996, Loftsson, 2015). These materials aid in the 
disintegration of the tablet into smaller fragment which provides a larger surface 
area for the dissolution of the API (Desai et al., 2016). 
Disintegrants are added to tablet formulations to encourage the disintegration 
of the tablet when ingested which then promotes the dissolution of the API. Various 
types of disintegrants are used for oral dosage tablets depending on the required 
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release time (Rowe et al., 2009). In other words, for fast release tablets super-
disintegrants are used which are capable of achieving full tablet disintegration 
within 30 s (Sunada and Bi, 2002). Some disintegrants release the tablet drug load in 
a time frame of 5 – 30 min, around the time that the tablet reaches the stomach.  
Table 2.1 General categories of the excipients used in pharmaceutical tablet formulations, 
their function and the ranges of w/w% typically used in formulations (Rowe et al., 2009). 
Excipient Function 
Approx. w/w% 
used in industry 
API The active pharmaceutical ingredient Variable 
Filler 
Primarily provides the bulk of the tablet mass, 
also improves flowability 
70 – 85 
Disintegrant 
Aids in the breakage of the tablet into smaller 
particles with a larger surface area for dissolution 
to occur 
2 – 5 
Binder 
Helps to maintain the structure of the tablet 
during production, transport and storage. 
2 – 5 
Lubricant 
Mainly to aid in the upkeep of the equipment 
used to produce the tablets as powders tend to 
stick and become difficult to remove 
1 – 2 
Other 
Such as stabilisers, pH modifiers, encapsulating 
agents, gelling agent 
1 – 10 
 
Binders and lubricants are added to a pharmaceutical formulation mainly to 
assist in the processing steps which produce the tablet. In other words, during 
granulation and tableting binders will help to agglomerate the primary powder and 
promote the formation of strong granules and tablets (Li et al., 2004). In some cases 
the materials used are cohesive and stick to the granulation and tableting 
machinery. Lubricants help to prevent material wastage due to adhesion by 
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reducing friction during processing and improve granule flow (Miller and York, 
1988, Miguélez-Morán et al., 2008). However, it has been found that addition of 
lubricant negatively affects tablet disintegration and dissolution. One reason is due 
to the hydrophobicity of lubricants causing water penetration to be hindered and 
consequently slowing disintegration (Wang et al., 2010). Additionally, it has been 
reported that tablets which contain lubricant are weakened due to the reduced 
cohesiveness (He et al., 2007). It should be noted that the extent of the effect of 
lubricant on the granular and tablet properties depend on the excipient properties 
(Otsuka et al., 2004). 
Fillers are used to bulk out the tablet’s content as the API may only occupy a 
small percentage of the total tablet weight (Loftsson, 2015). Fillers are generally inert 
and may possess additional qualities such as good taste and mouthfeel or 
disintegrant-like properties which are additional functions of their use in a 
pharmaceutical tablet formulation (Rowe et al., 2009). The filler used in a 
formulation will be selected depending on the function of the tablet and the 
compatibility of the other components. In this research microcrystalline cellulose 
and mannitol will be examined as they are widely used in pharmaceutical 
formulations (Ohrem et al., 2014, Rowe et al., 2009). 
Microcrystalline cellulose (MCC) is widely used in industry as a filler material 
due to its inertness and ductile properties, and will be analysed in this research 
(Rowe et al., 2009). The ductile nature of MCC allows for a high level of 
compression without the material undergoing brittle fracture. However, MCC is 
prone to a significant loss in tensile strength even at low pressures. Additionally, it 
is also a hygroscopic material and it has been found that moisture content within 
MCC influences properties such as tensile strength (Jivraj et al., 2000). MCC is also 
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known to have the ability to absorb water and swell, which suggests that it can also 
be used as a disintegrant (Thoorens et al., 2014). 
Mannitol is a non-hygroscopic filler material which makes it an ideal filler for 
use with moisture sensitive APIs. Mannitol is a brittle which means that the loss in 
compressibility even at high compaction pressures is limited (Wu and Sun, 2007, 
Rowe et al., 2009). It is commonly used in diabetic medications as, unlike some 
fillers such as sorbitol, it does not affect blood sugar levels in humans but still offers 
a “sweet” taste and good mouth-feel (Wagner et al., 2015). 
2.2.2 Granulation and Tableting 
During roller compaction (RC) granulation, material is compacted into 
ribbons. These ribbons are then crushed into granules. This first stress applied to the 
material in the process of producing tablets is the RC pressure used to compact the 
primary powder into ribbons. The second stress applied to the material is during 
tableting. 
Inghelbrecht and Remon conducted research in which the variation of the 
excipient and RC pressure were examined in terms of the tablet properties 
(Inghelbrecht and Remon, 1998b). Various grades of MCC were granulated with 
varying amounts of ibuprofen via roller compaction. Roller compaction pressures of 
2.3 and 6.9 MPa were used, and the tableting force was kept constant at 5.88 kN. It 
was determined that after granulation, tableting caused the various grades of MCC 
to undergo work hardening, in other words the deformability of the material 
decreased. It was reported that a higher RC pressure leads to the production of 
“better” ribbons and granules. It must be assumed that by “better” the authors 
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mean to say more well-compacted. However, it was found that the consequent 
tablet mechanical strength was poor. 
Much research has been conducted which agrees that the application of a 
higher RC pressure leads to increased ribbon and granule strength and decreased 
porosity (Chang et al., 2008, Allesø et al., 2016). It has also been reported that more 
porous tablets are more likely to disintegrate quickly due to the increased rate of 
penetration due to the higher number of available pores (Lowenthal, 1972). 
An increased RC pressure leads to less fines being produced, therefore the size 
distribution is improved (Wagner et al., 2013). However, the tablet tensile strength is 
widely documented to reduce with increasing RC pressure (Perez-Gandarillas et al., 
2016, Farber et al., 2008, He et al., 2007, Hadžović et al., 2011). This is generally 
termed as the “loss in compressibility” of a material. Tablet tensile strength in terms 
of the tablet porosity is termed as the compactibility (Leuenberger, 1982). An 
example for the reduction in tablet tensile strength due to RC pressure is shown in 
Figure 2.1. It should be noted that for the filler materials used in this research, roller 
compaction reduces the tensile strength at any RC pressure; directly compacted 
material produces the strongest tablets for these materials (Rowe et al., 2009).  
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Figure 2.1 Tablet tensile strength for a formulation containing 72 %Avicel PH102, 24 % 
lactose monohydrate, 3 % croscarmellose sodium and 1 % magnesium stearate. Tablets 
were produced using various compaction pressures using granulated material (40 or 80 
bar RC pressure), or directly compressed from the powder (Farber et al., 2008).  
Loss in compressibility of a material is a key issue with roller compaction. 
Some of the available literature suggests that the phenomenon being governed by 
the ribbon density. He et al. utilised RC to produce microcrystalline cellulose (MCC) 
tablets by compacting them at varying RC pressures (He et al., 2007). The tablet 
tensile strength and porosity were studied in terms of the ribbon solid fraction (SF); 
it was found that higher SF modestly decreased the tensile strength and porosity of 
the tablet. Similarly, Herting and Kleinebudde examined the compactibility was 
studied in terms of the ribbon porosity (Herting and Kleinebudde, 2007). It was 
found that a lower ribbon porosity led to weaker tablets, and that the tablet porosity 
was largely unaffected.  
Later research reported that the loss in compressibility of tablets following RC 
was due to the variation in particle size, depending on the RC pressure used. A 
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smaller granule size led to a higher specific surface area, and consequently higher 
tensile strength in the respective tablets (Herting and Kleinebudde, 2008).  
Figure 2.2 shows that Sun and Himmelspach also attributed that the reduced 
compactibility of roller compacted granules to the “size enlargement” of the 
particles which occurs during granulation (Sun and Himmelspach, 2006). It was 
reported that at “zero porosity” the tablet tensile strength still decreased depending 
on the number of compactions used. Mitra et al. utilised monodisperse granules to 
attribute the granule solid fraction to the consequent tablet tensile strength rather 
than the granule size (Mitra et al., 2015). However, in the research previously 
conducted the reduced compressibility phenomenon has not been examined in 
terms of the stresses applied during granulation and tableting. More importantly, 
the research has focussed largely on the granule size or density rather than granule 
strength and the bonding within a tablet.  
The tablet compressibility varies depending on the material and its properties 
(Tye et al., 2005). As previously mentioned, application of a higher compaction 
pressure during tableting has shown to increase the tablet tensile strength and 
decrease the tablet porosity (Sinka et al., 2009, Adolfsson and Nyström, 1996). This 
is due to the higher pressure leading to better particle-particle bonding and 
densification of the material (van der Voort Maarschalk et al., 1996). 
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Figure 2.2 Tablet compactibility graphs of sieved MCC granules produced by different 
numbers of roller compactions, highlighting that larger granules exhibit lower 
compactibility (Sun and Himmelspach, 2006). 
Hadžović et al. reported  that MCC tends to exhibit a great loss in 
compressibility and compactibility (Hadžović et al., 2011). Tablets were produced 
using RC granules compacted at 20 or 30 bar pressure and also by direct 
compression of the powder material. Varying forces were used to compress the 
granular material and the powder material into tablets. It was clearly seen that 
directly compressed tablets were stronger than the tablets produced using ribbons 
at the same tableting force. Additionally, a higher RC pressure led to a reduction in 
the tablet tensile strength. It was explained that this is an inherent property of 
plastic materials.  
Wu et al. examined the effect of the brittleness on the tabletability, i.e. the 
change in tablet tensile strength with compaction pressure used (Wu and Sun, 2007). 
Granule 
size 
Number of 
roller 
compactions 
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Mannitol was one of the materials which were examined in this research. This 
research also assumed that the size enlargement of granules is related to the loss in 
tabletability, as previously suggested by Sun and Himmelspach (Sun and 
Himmelspach, 2006). Therefore, mannitol was granulated using roller compaction 
and sieved into three size classes, then tabletted. 
Figure 2.3 Tabletability plot of the three sieved fractions of mannitol granules. Each point 
is one tablet. (Wu and Sun, 2007) 
It was reported that for all three size classes the tabletability exhibited a 
bilinear change with increasing compaction (see Figure 2.3). At lower compaction 
pressures the tabletability was almost identical for each size class. After a threshold, 
depending on the granules size class, a more pronounced difference in the 
tabletability was visible for each material. It was found that the larger granules 
produced the weakest tablets. By using linear regression it was found that the 
difference between the various slopes is significantly different (p < 0.05). This 
research statistically proved that brittle materials also undergo loss in tabletability.  
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It was hypothesised that this behaviour in brittle materials is due to the 
compaction pressure causing brittle fracture of the granular material rather than 
plastic deformation occurring. Reportedly, larger granules are more likely to 
undergo brittle fracture whereas smaller granules offer a larger surface area and 
therefore are more likely to undergo plastic deformation. Therefore a lower 
tabletability is observed for larger granules. However, it was explicitly stated by the 
researchers that it was not clear why the divergence in the tabletability occurred 
with higher compaction pressures (see Figure 2.3).  
2.3 Alternative Analysis Methods 
2.3.1 Disintegration of tablets 
Following the manufacture of tablets, disintegration testing is used to 
determine the tablet’s viability to deliver the drug load in the required manner. 
Tablet disintegration occurs due to liquid penetration into the solid dosage system 
which triggers multiple mechanisms to commence which instigate the tablet to 
break up (Luginbühl and Leuenberger, 1994). An initial mechanism which occurs is 
water penetration, which may lead to swelling, causing the breakup of the tablet 
matrix from inside the tablet. Due to the swelling, deformation of the particles 
ensues and causes water to be pulled into the tablet pores due to hydrophilic 
materials such as disintegrants, which disrupts particle-article bonding. Following 
the water uptake, saturated particles were reported to “repel” each other, leading to 
further tablet breakage. Erosion occurs, where particles are released from the tablet 
causing the area of the tablet to shrink in size. 
Various factors which affect tablet disintegration have been proposed by 
research such as wetting time and penetration (Peppas and Colombo, 1989). 
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Generally U.S. or European pharmaceutical tablet testing involves measuring the 
disintegration or the dissolution time of tablets using a standard pharmacopoeia 
method (Bai et al., 2011). However, it is measured as a finite time point at the end of 
the tablet disintegration process. No information regarding the mechanisms of 
disintegration, such as swelling and erosion, is obtained.   
In order to gain information regarding the processes occurring during tablet 
disintegration, analysis methods have been presented in research using various 
approaches. This was done by measurement of the parameter disintegration force 
(Colombo et al., 1980, Colombo et al., 1984, Peppas et al., 1989), by using MRI to 
visualise and image disintegration (Shiko et al., 2011, Quodbach et al., 2014b, 
Quodbach et al., 2014a, Quodbach and Kleinebudde, 2014) or utilising particle 
sizing methods to elevate the existing USP apparatus to be capable of linking tablet 
disintegration and dissolution (Wilson et al., 2012).  
By using a texture analyser which mimics a patient’s mouth, research was 
carried out to determine whether accurate disintegration data of rapidly 
disintegrating tablets could be obtained (Abdelbary et al., 2005). The results of the 
experiment were compared to results obtained through testing the same tablets 
using human volunteers. The simulate test was carried out using artificial saliva. 
Overall, a good correlation was seen with respect to the mouth-feel, penetration, 
disintegration profile and tablet thickness. While this study was able to replicate the 
disintegration behaviour with a focus on how it affects the patient, the processes 
occurring during disintegration were not able to be realised. 
Mesnier et al. utilised a novel method to image the disintegration of tablets in 
a quantifiable manner (Mesnier et al., 2013). A Flow Cell was constructed (see 
Figure 2.4), consisting of a mesh for the placement of the tablet, a viewing window 
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to enable imaging of the tablet. Water was introduced through the lower inlet into 
the cell and exited through the upper outlet into a basin. This ensured that the 
released particles from the tablet moved in the same direction as the water flow, and 
could be imaged without being counted twice. Colour images were obtained during 
tablet disintegration using a 16 MP camera at a rate of 10 images per second. The 
images (see Figure 2.4a) were then converted into 8bit grayscale images then 
thresholded to obtain a binary images that were used to distinguish between 
released particles, the tablet and the background (see Figure 2.4b). Using the space 
occupied by the particles in the binary image, the equivalent area of those particles 
was calculated. The boundaries of the tablet were also established so that the 
variation of tablet thickness and diameter could also be observed.  
Figure 2.4 Illustration of Flow Cell and a) typical image obtained during disintegration 
testing using the Flow Cell. b) Converted binary image after thresholding (white – tablet 
and particles, and black – background) (Mesnier et al., 2013). 
a. 
b. 
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The study aimed to determine the effectiveness of disintegrants on tablet 
disintegration. Tablets containing (i) 100 % maltodextrin DE 21 and (ii) 98 % 
maltodextrin DE 21 and 2 % croscarmellose sodium powder mixtures were directly 
compressed. The tablets produced had the dimensions of 12 mm in diameter and     
6 mm in height.  
As a comparison of the dissolution and disintegration were the main 
investigative points, tablet characterisation was carried out to identify any other 
variables. Both the pure maltodextrin tablets and maltodextrin with 2 % disintegrant 
tablets were calculated to have similar porosities and tablet tensile strengths. Due to 
the similar porosity and tensile strength values obtained, it was assumed that these 
properties would not influence the dissolution and disintegration analysis.  
Figure 2.5 shows the dissolution profiles obtained from conductivity 
measurements showed that the tablets containing 2 % disintegrant dissolved faster 
than pure maltodextrin tablets. But from this study it was clear that no further 
information is obtainable through dissolution testing via conductivity, such as the 
concentration and structure of the soluble material in solution at any given time.  
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Figure 2.5 Dissolution profiles of tablets made of 100% maltodextrin DE 21 and 
maltodextrin DE 21 containing 2% of disintegrant (croscarmellose sodium). (Mesnier et 
al., 2013) 
The Flow Cell (see Figure 2.4) was used to capture images of the 
disintegration of the tablets which were then converted to binary images. A 
MATLAB program was used to identify the released particles and tablet 
dimensions. The variation of the tablet dimensions was observed, as well as the 
particle size distribution of the released particles, throughout the disintegration 
process.  
Analysis of the evolution of tablet dimensions with respect to time showed 
that tablets containing 2 % disintegrant decreased in both the tablet thickness and 
diameter faster than pure maltodextrin tablets (see Figure 2.6). The thickness of the 
tablet appeared to be decreasing at a faster rate at approximately 90 s. It was 
hypothesised that this phenomenon was due to the increasing uptake of water into 
the tablet causing activation of the disintegrant located inside the tablet. It was 
noted that swelling did not occur during testing; maltodextrin does not swell when 
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in contact with water, even with 2 % disintegrant, as this is not a characteristic of 
this material. The change in tablet dimensions was generally a steady straight 
decline. 
Figure 2.6 a) Variation of tablet thickness with time for tablets made of 100% maltodextrin 
DE 21 and maltodextrin DE 21 containing 2% of disintegrant. b) Variation of tablet 
diameter with time for tablets made of 100% maltodextrin DE 21 and maltodextrin DE 21 
containing 2% of disintegrant. (Mesnier et al., 2013) 
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The size distributions of the particles released showed that even without the 
presence of disintegrant, particles were still released from the tablets due to a 
phenomenon called “erosion”. Erosion occurs due to the rupture of inter-particle 
bonding or polymer chains following contact with water. Tablets containing 2 % 
disintegrant released a higher percentage of larger particles than pure maltodextrin 
tablets (see Figure 2.7). Maltodextrin primary particles were also tested to establish 
whether smaller sized particles were detectable by this analysis method. It was 
found that smaller particles could be detected, and therefore it was determined that 
in both tablet formulations aggregates rather than primary particles were released. 
This demonstrates that aggregates are formed during compression, where the 
bonding of primary particles occurs due to the tableting stress applied.  
Figure 2.7 Density distribution of the particles liberated during the disintegration of 
tablets of maltodextrin DE21 and tablets of maltodextrin DE21 containing 2% of 
disintegrants (croscarmellose sodium) obtained for the first 150s. (Mesnier et al., 2013) 
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In the presence of disintegrant the total number of particles released and the 
mean particle size was found to be higher. This was rationalised to be due to the 
disintegrant causing fractures inside the tablet, allowing for larger particles to be 
liberated. The particle release data was grouped into 2 time sets rather than with 
time as the tablet thickness and diameter were previously presented. After 90 s of 
the disintegration, the number of particles released increased in size for the tablets 
containing disintegrant (see Figure 2.6 and Figure 2.8). This time period 
corresponded to the change in regime during the decrease of tablet thickness. 
Mesnier hypothesised three possible reasons for this to occur. Firstly, this 
phenomenon was attributed to the increasing diffusion coefficient of water as the 
penetration of water into the tablet increases. Secondly, it was suggested that a 
gradient of tablet density exists within a tablet, meaning that the top and bottom of 
a tablet are denser than the mid-section. Therefore, the mid-section of a tablet has a 
higher porosity, meaning that the penetration of water increases once this region is 
reached. This consequently causes a faster breakage of the tablet. Thirdly, the water 
may eventually be reaching and activating the disintegrant located inside the tablet. 
While the reasoning outlined need validation, the most important point to be made 
is that these nuanced variations in tablet disintegration would not have been 
detected if a conventional USP method was used. However, the rationale behind the 
differences in particle release sizes was not related to the tablet material properties. 
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Figure 2.8 Variation of the number of the particles liberated during the disintegration of 
tablets of maltodextrin DE21 containing 2% of disintegrant (croscarmellose sodium) 
plotted for two different times: particles liberated from the start to 90s, and particle 
liberated after 90s to 150s. (Mesnier et al., 2013) 
Wilson et al. used population balance modelling to link the dissolution 
process to disintegration by utilising an optical analysis method (Wilson et al., 
2012). Tablet disintegration and dissolution was analysed using the standard USP 
method, and also by utilising a modified USP apparatus capable of monitoring 
particle release. Two batches of tablets (termed Tablet A and Tablet B for 
convenience) with differing physical properties were prepared from the same 
formulation using wet granulation (see Table 2.2). Tablet properties were altered 
through variation in the granulation and compression processes, resulting in tablets 
with differing crushing forces. Tablet A had a lower crushing force of 80 N, whereas 
Tablet B had a value of 111 N.  
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Table 2.2 Tablet formulation. 
Material Percentage w/w 
Drug substance 5 
Insoluble excipient 15 
Soluble excipient 80 
 
Firstly, the disintegration time was measured as per the standard USP method 
and the time taken for the tablet fragments to fall through the mesh was identified 
as the disintegration time. For Tablet A a much shorter disintegration time was 
observed than for Tablet B. Standard dissolution testing was carried out in pH 1.4 
NaCl/HCl dissolution medium with a paddle speed of 60 rpm. UV measurements at 
343 nm were taken at various intervals to determine extent of drug dissolution, 
through comparison with a drug substance reference standard. Tablet A displayed a 
fast initial rate of release, then a slower phase which reached around 95 % after 60 
min. On the other hand, Tablet B presented a generally slower release rate which 
reached around 75 % drug release after 60 min. Thus a link between fast 
disintegration and fast dissolution for weaker tablets was established; however, no 
mechanistic insight was obtained through standard testing.  
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Figure 2.9 Dissolution profile obtained using UV analysis for Tablet A (■) and Tablet B 
(▲). (Wilson et al., 2012) 
A standard USP apparatus, as described previously, was modified and 
connected directly to QICPIC equipment to investigate the number and size of 
particulates entrained in solution, as a function of time, during dissolution. 
Typically QICPIC equipment is used to measure particle size distributions of solid 
dry samples, however with the aid of the LIXELL unit attachment liquid dispersions 
are capable of being analysed. During testing the disintegration medium was 
pumped through the LIXELL system to analyse the particle release. 
Firstly, it was observed that Tablet A released particles at a faster rate than 
Tablet B (see Figure 2.10). Tablet A reached its maximum number of suspended 
particles after 5 min, whereas Tablet B reached its maximum after 30 min. The 
number of entrained particles decreased gradually after the maximum is reached for 
both Tablet A and B; the decline is more pronounced for Tablet A than Tablet B. It 
was proposed that the trend for the decrease in number of entrained particles 
suggests that eventually the number of entrained particles will reach a constant 
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value, which could correspond to the presence of 15 % w/w insoluble excipients in 
the formulation. 
Figure 2.10 Number of particles released with time for Tablet A (■) and Tablet B (▲). 
(Wilson et al., 2012) 
However, it seemed that Tablet A and B were progressing towards different 
final entrained particle values. The cause of the difference was deemed to be 
unclear; whether this was due to the generally slower rate of dissolution of Tablet B 
or a difference in the degree of insoluble particle agglomeration was not confirmed.  
Nevertheless, it was seen that a strong link between the rate of change in entrained 
particles and the rate of dissolution exists.  
The mass weighted size distributions (see Figure 2.11) were observed and 
similar size ranges were detected for both Tablet A and B. However, the ratios of the 
various size ranges varied during dissolution. In the case of Tablet A the number of 
smaller particles decreased with time, whereas the number of larger particles 
remained fairly constant throughout the dissolution. On the other hand Tablet B 
showed that the number of particles remained relatively constant throughout the 
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dissolution time. The number of particles in each respective size range corresponds 
to the soluble and insoluble excipients present in the formulation; therefore, the 
decreasing number of particles in the smaller size range was attributed to the 
dissolution of the dispersed drug particles. The volume weighted D50 values as a 
function of time remained relatively constant for Tablet A. Tablet B however 
presented a reduction in the D50 value with time. It was suggested that this could 
represent a secondary step during dissolution where Tablet B undergoes a reduction 
in size. 
Figure 2.11 Mass weighted particle size distributions of tablet A (top images) and tablet B 
(bottom image). Left side images show the total distribution; right side images show three 
small size classes in the approximate location of the drug substance. (Wilson et al., 2012) 
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To correlate the different tablet dissolution profiles and the rate of particle 
release for Tablets A and B, the rate and extent of dissolution was considered. It was 
found that Tablet A, which has a faster rate of dissolution, tends to have more 
particles entrained in solution. It can be assumed that the rate of drug dissolution is 
proportional to the number of particles entrained and the rate of particle release, as 
a higher number of particles means a larger particle surface area is available for 
dissolution to occur. 
While this method has been proven to provide additional knowledge during 
disintegration analysis, the methodology contains some flaws which may influence 
the results obtained. Due to the nature of the modified USP equipment, the 
disintegration media is required to be pumped to the QICPIC viewing window for 
the particle imaging analysis to occur. Therefore, it must be considered that the 
entrained particles are subjected to further mechanical stress in addition to the 
existing agitation of the USP apparatus. This suggests that the entrained particles 
may undergo breakage, meaning that when they are eventually measured, the size 
observed would be significantly misrepresented.  
2.3.2 Dissolution of tablets 
Dissolution of tablets is complex and involves many processes occurring 
simultaneously. Dissolution can be defined as the process of solid soluble material 
transitioning into a solute state. Tablet disintegration is the breakage of the tablet 
into smaller pieces following contact with the liquid media, thus increasing the 
surface area available for dissolution to occur (Desai et al., 2016). Disintegrants are 
therefore added to pharmaceutical tablets to speed up the dissolution process, for 
example in fast release tablets (Pabari and Ramtoola, 2012). In literature, it has 
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previously been suggested that dissolution of a soluble material is not limited by 
disintegration (see Figure 2.12); dissolution is also possible from the solid dosage 
form. However, disintegration offers additional routes for dissolution to occur 
(Ibrahim and Sallam, 1993, Wagner, 1969). Disintegration can be thought of as an 
integral process for the dissolution of tablets; both processes coincide with and 
affect each other. However, disintegration and dissolution are rarely studied as 
mutual processes. 
Figure 2.12 Various proposed routes for dissolution to occur. (Ibrahim and Sallam, 1993) 
The time taken for a tablet to disintegrate is measured using a standardised 
pharmacopoeial testing apparatus. Measurement of the dissolution of the active 
pharmaceutical ingredient (API) dissolution time is carried out via chemical 
analysis (Katzhendler et al., 1997). The standard United States Pharmacopeial (USP) 
methods used to analyse dissolution are outlined in Section 2.2.  
Current methods used in industry to analyse tablet dissolution have been 
challenged through research. Röst and Quist studied effect of varying the stirring 
conditions, a fundamental component of the USP equipment, on the dissolution of 
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United States Pharmacopoeial Convention (USP) prednisone calibrator tablets (Röst 
and Quist, 2003). For this research an automated USP-II dissolution test apparatus 
was fitted with a special paddle-propeller. Dissolution tests were carried out whilst 
altering the stirring conditions through variation of the paddle to either a pulling or 
pushing propeller by changing the angle of the paddle blades. UV analysis was 
utilised to determine the API release. The fastest dissolution was obtained with the 
paddle-propeller blade angle at around +30°, providing a pushing, downward flow 
at the centre of the vessel. This contradicts previous research which suggested a 
paddle at a blade angle of 0° allowed the best stirring. This research suggests that 
the USP dissolution analysis methods are not as accurate as intended. Measurement 
of the exact dissolution time, i.e. the rate of the API release, can vary depending on 
the set-up of the apparatus. 
Various methods have been explored in research to investigate dissolution in 
a manner which allows for additional information to be gained when compared to 
the standard USP testing methods. Delalonde stated that the kinetics of dissolution 
is dependent on various phenomena such as mass transfer, fluid phase filtration and 
volume variation (Delalonde and Ruiz, 2008). In an attempt to understand the 
different processes involved in dissolution, a hydro-textural approach was 
integrated into the existing European Pharmacopoeia standard tablet dissolution 
analysis. A discontinuous and continuous analysis of tablet dissolution was 
performed on the theophylline tablets which were produced at varying forces.  
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Figure 2.13 Evolution of a) Ms, b) V and c) Mw with time for theophylline tablets produced 
using varying tableting forces. (Delalonde and Ruiz, 2008) 
The tablets were characterised beforehand by their initial mass and volume 
(M0 and V0, respectively) for later calculations (Delalonde and Ruiz, 2008). As seen 
in Figure 2.13 it was found that the evolution of the remaining dry mass (Ms) is 
independent of compacting force, and both methods were in close agreement. The 
a 
b 
c 
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evolution of tablet volume (V) vs. time suggested that whilst compaction force 
influences dissolution, the effects are limited to the outer tablet surface. The 
evolution of penetrated water mass (Mw) as a function of time was studied.  The 
penetration of water was proposed to occur in 3 stages. The first stage was 
explained as water penetration occurring through capillary action until equilibrium 
is reached between the air and water pressure inside the tablet pores. The second 
stage corresponded to water enclosing the tablet and the porous structures. This 
causes air inside the tablet to become entrapped, limiting the amount of water 
which can penetrate the tablet until the air escapes. The final stage was related to the 
gradual dissolution occurring at the tablet periphery which eventually opens 
porous pathways for air outflow, leading to complete dissolution. A higher tablet 
compaction force led to a slower penetration of water into the tablet. Investigation 
of the variation in the degree of tablet saturation as a function of time also revealed 
that the tablet samples are never fully saturated, and the cores remain dry until 
near-complete dissolution. From this method, the disintegration of the tablet was 
also considered in terms of the change in tablet mass and volume. However, the 
reasoning behind any differences in the changing tablet dimensions is speculative. 
A visual monitoring system would provide further evidence to support the 
reasoning given. 
The dissolution kinetics of theophylline granules and dry tablets were 
compared using standard dissolution test apparatus (Delalonde and Ruiz, 2008). At 
both 50 and 100 rpm it was found that granules dissolve faster than the tablets, due 
to the increased surface area in contact with the dissolution media. For both 
granules and tablets dissolution occurred faster at 100 rpm, which suggests the 
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limiting factor is the rate of diffusion from the boundary layer and is not related to 
molecular diffusion rate.  
Near-infrared (NIR) spectroscopy was employed to investigate the dissolution 
process in pharmaceutical tablets at a molecular level (Hattori and Otsuka, 2011). 
Tablets were prepared containing either α-lactose monohydrate (La) or trehalose 
(Tr) fillers, magnesium stearate (MgSt) and riboflavin (RF) at varying porosity (H-
high, M-medium, L-low). La-H, La-M, La-L and Tr-M tablets were characterised by 
their mechanical strength, disintegration time and dissolution profiles.  
 UV spectroscopy dissolution profiles indicated that the porosity of the tablets 
influenced the speed of dissolution, with the most porous La-H tablets dissolving at 
the quickest rate. However, it was found that the initial dissolution was governed 
by tablet disintegration; water penetration profiles of the tablets were obtained to 
investigate further. The Lucas-Washburn theory was utilised to explain the 
behaviour, which is summarised by Equation 2.1.  
𝐖𝟐 =
𝛒𝐥𝐢𝐪
𝟐𝐀𝐚𝐯𝐞
𝟐𝛄 𝐜𝐨𝐬 𝛉
𝟐𝛈𝐒
 
𝛆𝟑
𝟏 − 𝛆
 
Equation 2.1  
where W is the mass of penetrated liquid; pliq and η are the density and viscosity of the 
liquid, respectively; γ and θ are the surface tension and the contact angle between the 
liquid and particle layer, respectively; Aave, ε and S are the averaged sectional area, 
porosity and the specific surface of the particle layer, respectively. 
W2 is linearly proportional to t (Equation 2.1) for that reason straight lines 
were fitted to W2 vs. t for all sample tablets. From Equation 2.1 it can be seen that 
porosity (ε) directly contributes to the penetration rate, which was confirmed by the 
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comparable water penetration profiles of La-M and Tr-M tablets, whereas their 
respective dissolution profiles were dissimilar.  
Figure 2.14 A) water penetration profiles for La-H (∆), La-M (□), La-L (○) and Tr-M (■) vs 
time and B) W2 vs time. Solid lines are fit to linear lines on the basis of the Lucas-
Washburn theory. (Hattori and Otsuka, 2011) 
The interactions between water molecules and the tablet excipients were 
studied by utilising NIR spectroscopy and the perturbation-correlation moving-
window two-dimensional correlation spectroscopy (PCMW-2DCS) technique 
(Hattori and Otsuka, 2011). Spectral changes upon water penetration in the tablet 
samples suggested that dissolution was occurring through two processes; (i) 
interaction between water and tablet disaccharide through water penetration, 
Literature Review 
57 
 
depending on disaccharide hydration number; (ii) saturated disaccharide leading 
dissolution and diffusion in water, depending on tablet porosity.  
Overall, it was confirmed that tablet porosity and the rate of water penetration 
both play a role in the tablet dissolution by using NIR spectroscopic measurements. 
While this is a viable on-line method for the analysis of tablets, the tablet dissolution 
is only considered in relation to the whole tablet swelling. The particle release, 
which is a vital mechanism which aids tablet disintegration and consequently 
dissolution, is not deliberated. 
Magnetic resonance imaging (MRI) is generally used in the medical field for 
clinical diagnoses; however, recent advances have enabled utilisation of laboratory-
scale MRI equipment in investigating the dissolution process of pharmaceutical 
tablets (Nott, 2010). A low-field MRI instrument integrated with a MRI compatible 
USP-4 dissolution apparatus was used to image the various stages during the 
dissolution of USP standard gel matrix tablets. The dissolution apparatus contained 
glass beads to ensure laminar flow throughout and unrestricted swelling of the 
tablets. A UV spectrometer was also fitted to the equipment to simultaneously 
monitor the concentration of drug release during dissolution. By varying the 
contour intensities of the MR images obtained during dissolution it was possible to 
differentiate between, and calculate the area of the whole tablet and non-hydrated 
core at each stage. This provided useful information as to the hydration process 
during dissolution and can be used to investigate the effects of hydration on overall 
dissolution rates.  
From the methods previously mentioned (Hattori and Otsuka, 2011, Nott, 
2010, Röst and Quist, 2003), it was noticed that the preferred dissolution analysis 
technique used was UV spectroscopy. UV spectroscopy is an unreliable technique if 
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multiple soluble components exist within the tablet being analysed, as the 
respective spectra may overlap and therefore the calculated concentrations in 
solution may be inaccurate. However, in terms of the effect of tablet porosity, it has 
been generally found that more porous tablets propagate faster dissolution and 
disintegration. 
Coombes et al. used 1H NMR to monitor dissolution of commercially available 
cold medicine tablets containing a mixture of 4 difference compounds (Coombes et 
al., 2014). NMR is typically used as a characterisation technique to determine the 
chemical structure of a compound. Due to the accuracy of the method it was 
possible to determine the increase in concentration of each individual component 
with time. While this is advantageous due to the accuracy of the measurement 
compared to technique such as UV, it is an off-line technique. This means that the 
concentrations in solution are possibly not an accurate representation of the 
dissolved percentage at the time that the sample was taken. 
1H NMR was also used in conjunction with MRI to monitor tablet dissolution 
and visually monitor tablet disintegration (Wren et al., 2017). Tablets were produced 
using mannitol and sodium starch glycolate which was granulated. Wet granulation 
parameters and the granule size fractions were varied. It was found that tablets 
which were produced using the highest granulation intensity and larger granules 
decreased in tablet volume at the slowest rate and released mannitol at the slowest 
rate. 
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Chapter 3. Roller 
Compaction and 
Tableting 
3.1 Introduction 
This Chapter will explore the effect of the stresses during roller compaction 
(RC) granulation and tableting on ribbon and tablet properties. Ribbon porosity 
affects the consequent tablet porosity, which is one of the main properties which 
affect the tablet dissolution and disintegration. It has been reported in literature that 
porous tablets will disintegrate quickly due to the rapid uptake of water through the 
tablets pores (Pitt and Sinka, 2007). The tablet strength and porosity are 
fundamentally determined by the roller compaction and tableting stresses used 
during production. Careful manipulation of these parameters can lead to the 
desired properties manifesting in the consequent tablets. 
When a tablet is produced using roller compaction granulation, the primary 
powder is subjected to two key stresses; the first stress is during granulation 
between the rollers and the second stress is during tableting. Compression of a 
material through the application of stress leads to a decrease in the material volume 
and changes in the mechanical strength of said material due to the formation of 
particle-particle bonding. Therefore, when materials undergo granulation and 
tableting, the tablet properties, such as tensile strength and porosity, are affected by 
these stress applied at each stage. The application of stress can be both beneficial 
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and detrimental to the material properties within a tablet, as there is a balance 
between making the material stronger or weaker as a whole with more stress 
applied (Johansson et al., 1995, van der Voort Maarschalk et al., 1996, Zea et al., 
2013). 
In literature, the tablet tensile strength and porosity are key tablet properties 
which are examined to quantify tablet functionality. Some basic terms which are 
used to describe these properties are as follows. The tensile strength and porosity of 
tablet is defined as the “compactibility”. This tensile strength of a tablet in terms of 
the tableting compaction pressure used is termed as the “tabletability” of a material. 
The tablet porosity in terms of the tableting compaction pressure used is termed as 
the “compressibility”.  
In this chapter the impact of the two main stresses applied during tablet 
production, roller compaction and tableting, will be investigated. The effect of the 
RC pressure and tableting force on the tablet compactibility will be examined by 
measurement of the tensile strength and porosity. X-ray tomography, which is 
capable of viewing the internal tablet structure (Busignies et al., 2006), was also used 
to elucidate the effect of these stresses on the internal structure of the tablet. 
3.2 Materials 
In Chapter 3 - Chapter 5 placebo mixtures will be analysed to determine the 
effect of granulating and tableting a ductile and a brittle material. The excipient 
materials were used as received, unless otherwise stated.  
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3.2.1 Mannitol (Pearlitol 200SD) 
Mannitol Pearlitol 200SD from Roquette (Lestrem, France) was studied as it is 
a soluble and brittle filler material. Mannitol is formed by the catalytic or electrolytic 
reduction of monosaccharides such as mannose and glucose. In this case the 
mannitol was formed by spray drying, and is a white, odourless powder. Mannitol 
is commonly used in the pharmaceutical and food industry due its sweet taste and 
“mouth-feel” (Rowe et al., 2009).  Figure 3.1 shows the slightly spherical shape of 
spray dried mannitol powder from SEM images. It is capable of being directly 
compressed or granulated by either wet or dry granulation. 
Figure 3.1 SEM images of Mannitol Pearlitol 200SD at x50 and x250 magnification. 
3.2.2 Microcrystalline cellulose (Avicel PH-101) 
Microcrystalline cellulose (MCC) Avicel PH101 from Sigma Aldrich (St. Louis, 
USA) was also studied as filler. MCC is an insoluble and ductile material. It is a 
purified, partially depolymerised cellulose which occurs as a white, odourless, 
crystalline powder (Rowe et al., 2009). It well suited for direct compression and wet 
or dry granulation. MCC is able to undergo significant plastic deformation and form 
strong compacts. Therefore, it is widely used in the pharmaceutical industry as a 
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binder and filler; in some cases it exhibits disintegrant behaviour as it readily 
absorbs and swells when in contact with water. SEM images of MCC are shown in 
and Figure 3.2 where the elongated crystalline structure is clear.  
Figure 3.2 SEM images of MCC Avicel PH101 at x50 and x250 magnification. 
3.2.3 Magnesium stearate (Mallinkrodt) 
Magnesium stearate Mallinkrodt (St. Louis, USA) was used as a lubricant 
during granulation and tableting. It is a fine, white, greasy powder which is highly 
hydrophobic (Rowe et al., 2009) 
3.2.4 Filler particle size and solubility 
The particle size values and solubility data are shown in Table 3.1. Mannitol 
generally has a larger primary powder size. 
Table 3.1 D10, D50 and D90 values and the solubility data for the filler materials which were 
examined (Rowe et al., 2009). 
Material D10 D50 D90 
Solubility in water 
(part/part) 
Mannitol (200SD) 100 173 250 1 in 5.5 
MCC (PH101) 14-30 40-75 77-156 [insoluble] 
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3.2.5 Binary placebo mixtures 
The placebo binary mixtures which will be analysed in the following Chapters 
are outlined in Table 3.2. The percentages of the fillers mannitol and MCC are 
varied, as well as the processing parameters.  
Table 3.2 Formulations and processing conditions used to produce binary mixture 
granules with abbreviations. 
Abbreviations Mannitol (%) MCC (%) 
Man100:MCC0 100 0 
Man75:MCC25 75 25 
Man50:MCC50 50 50 
Man25:MCC75 25 75 
Man0:MCC100 0 100 
 
3.3 Methods 
3.3.1 Scanning electron microscopy (SEM) 
A CamScan S2 scanning electron microscope (CamScan, UK) was used to 
obtain electron micrographs of primary powder. The equipment operates under 
vacuum conditions at 10 kV. The tablets were pre-coated with gold to improve the 
conductivity of the material using an Emscope SC 500A sputter coater. 
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3.3.2 Roller compaction 
Before granulation, the powders were pre-mixed using a Roto Junior 
Zanchetta & C (Lucca, Italy) mixer at 100 rpm for 5 min. The mixtures were then 
conditioned in a Binder KMF240 Climactic humidity chamber (Tuttlingen, 
Germany) at 25 °C and 40 % relative humidity for 3 days to ensure constant 
moisture content within the powders. The formulations that were analysed are 
outlined in the respective Chapters. The main two materials which were used are 
mannitol and microcrystalline cellulose (MCC). The moisture content of mannitol 
increases drastically at > 75 % relative humidity and MCC is hygroscopic and 
therefore the conditioning is required so that the powder properties remain constant 
for all formulations (Rowe et al., 2009).  
All ribbons and granules were produced using an Alexanderwerk WP 120 
PHARMA (Remscheid, Germany) roller compactor. A diagram of the roller 
compactor equipment which was used in this research, with horizontally mounted 
rollers, is illustrated in Figure 3.3.  
For the roller compactor used in this research, the powder is introduced 
through the hopper and into the screw feeder. This conveys the material through 
the two counter current rollers which apply stress to densify the material and 
produces a compacted ribbon. The ribbon compact can then be crushed, for example 
by a crushing mill, which produces granules with improved properties such as 
flowability and homogeneity (i.e. less segregation of component materials within 
the formulation). The granules can then be tabletted into solid oral dosage forms. 
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Figure 3.3 Photograph and schematic of the roller compactor used in this research. 
In this research, the conditioned powder mixtures were roller compacted 
using a screw speed of 19 rpm and roller speed of 6 rpm. These settings were used 
as they were suitable for the materials that were studied in this research, meaning 
that the material was able to be carried through the equipment with no blockages. 
The roller dimensions were as follows; the roller width used was 0.04 m, the roller 
diameter was 0.12 m and the roller gap used was 0.003 m. Two meshes were used to 
crush ribbons into granules, where the larger mesh had a screen size of 3.25 mm and 
the smaller mesh had a screen size of 1.5 mm. Magnesium stearate was used as an 
external lubricant during roller compaction to prevent sticking.  
In this research the stress applied to a material during the journey of 
producing a tablet is a key parameter that will be examined.  The first stress applied 
Powder 
Granules 
Hopper 
Screw 
feeder 
Rollers 
Crushers 
with mesh 
screens 
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to a material is during RC, as pressure is applied between the rollers to compact the 
powder into ribbons. Therefore, two RC pressures were chosen, 20 and 100 bar, to 
ensure that the ribbons which were produced would exhibit a range of properties 
which can be examined.  
3.3.3 Ring shear tester 
A RST-XS Ring Shear Tester (Dietmar-Schulze, Germany) was used to 
determine the effective angle of internal friction (δE) and the angle of wall friction 
(ϕw). The measurements were carried out using 10 kPa normal load at preshear.  
3.3.4 Johanson Model 
According to the Johanson model, the pressure gradients experienced by the 
powder material during roller compaction can be determined by inputting the 
relevant powder properties. The model can be used to link the powder properties to 
the processing parameters used, and furthermore be used to relate the hydraulic 
pressure applied by the rolls to the peak pressure applied to the material as stress.  
Equation 3.1 and Equation 3.2 were used to determine the pressures gradients 
experienced by the materials in the nip (no-slip) and slip regions during roller 
compactions (Johanson, 1965, Reynolds et al., 2010). The equations were solved to 
determine the nip angle (α) where the boundary condition between the material and 
the rolls changes from a slip condition to a nip condition (see Figure 3.4) (Reynolds 
et al., 2010, Souihi et al., 2015). By using Equation 3.3 and Equation 3.4, the δE and 
ϕw values for each material were used to determine parameters A and υ. 
𝐝𝛔
𝐝𝐱
|
𝐒𝐥𝐢𝐩
=  
𝟒𝛔(𝛑 𝟐⁄ − 𝛉− 𝛖)𝐭𝐚𝐧𝛅𝐄
𝐃
𝟐⁄ (𝟏+ 
𝐒
𝐃⁄ −𝐜𝐨𝐬𝛉)(𝐜𝐨𝐭(𝐀− 𝛍)−𝐜𝐨𝐭(𝐀+ 𝛍))
  
Equation 3.1 
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𝐝𝛔
𝐝𝐱
|
𝐍𝐢𝐩
=  
𝐊𝛔𝛉(𝟐𝐜𝐨𝐬𝛉−𝟏− 
𝐒
𝐃⁄ )𝐭𝐚𝐧𝛉
𝐃
𝟐⁄ (𝟏 + 
𝐒
𝐃⁄ −𝐜𝐨𝐬𝛉)𝐜𝐨𝐬𝛉
  
Equation 3.2
where 
𝐀 =  
𝛉+ 𝛖+ 
𝛑
𝟐
𝟐
  
Equation 3.3 
𝟐𝛖 =  𝛑 − 𝐚𝐫𝐜𝐬𝐢𝐧 (
𝐬𝐢𝐧𝛟𝐰
𝐬𝐢𝐧𝛅𝐄
) −  𝛟𝐰   
Equation 3.4 
 
Figure 3.4 Schematic diagram showing the roller compaction process. 
To relate the hydraulic pressure (Rf) applied to the material to the peak 
pressure (σRC) Equation 3.5 and Equation 3.6 were used which represent the 
relationship between the processing parameters used. By determining the 
compressibility (K) and the nip angle (α) as mentioned previously, Equation 3.5 and 
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Equation 3.6 can be solved to relate the applied hydraulic pressure (Rf) to the peak 
pressure (σRC) as stress. 
𝐑𝐟 =  
𝛔𝐑𝐂𝐖𝐃𝐅
𝟐
  Equation 3.5 
𝐅 =  ∫ [
𝐒
𝐃⁄
(𝟏+𝐒 𝐃⁄ −𝐜𝐨𝐬𝛉)𝐜𝐨𝐬𝛉
]
𝐊
𝛉=𝛂(𝛅𝐄,∅𝐄,𝐊
𝛉=𝟎
𝐜𝐨𝐬𝛉𝐝𝛉  
Equation 3.6 
where W is the roller width, D is the roller diameter, S is the roller separation 
and K is the compressibility. In this study the values used were as follows; W = 0.04 
m, D = 0.12 m and S = 0.003 m. 
The compressibility factor (K) in terms of the tablet density was determined 
for the Man100:MCC0 and Man0:MCC100 formulations by using Equation 3.7.  
𝐥𝐨𝐠 𝛔𝐭𝐚𝐛 =  
𝟏
𝐊
𝐥𝐨𝐠 𝛒𝐭𝐚𝐛 + 𝐥𝐨𝐠 𝛄𝟎 
Equation 3.7  
where σTS is the tableting stress, K is the compressibility, ρtab is the tablet 
density and γ0 is the preconsolidation relative density. The δE, ϕw and K values used 
in the calculations are stated in Table 3.3. 
Table 3.3 The effective angle of internal friction (δE), the angle of wall friction (ϕw) and 
compressibility (K) values. 
 
 δE (°) ϕw (°) K 
Mannitol 36.1 8.9 7.2 
MCC 44.5 6.8 4.8 
Roller Compaction and Tableting 
69 
 
Table 3.4 shows the values obtained for the RC stress (σRC); these values can 
then be related with the tableting stress (σTS) to determine the different degrees of 
stress applied during the production of a tablet, i.e. during roller compaction and 
tableting. 
Table 3.4 The values for the stress applied when roller compaction pressures of 20 and 100 
bar are used during granulation for Man100:MCC0 and Man0:MCC100 formulations. 
Abbreviations 
RC hydraulic pressure 
used (bar) 
σRC RC stress (MPa) 
Man100:MCC0 20 40 
Man100:MCC0 100 199 
Man0:MCC100 20 34 
Man0:MCC100 100 171 
 
3.3.5 Particle size distribution 
The size distributions of the granules were determined using a Sympatec 
QICPIC (Clausthal-Zellerfeld, Germany) particle size analysis apparatus, fitted with 
the VIBRI vibratory feeding unit and GRADIS dispersion unit. The QICPIC utilises a 
high speed camera with a short exposure time to obtain images of the particles. The 
images are then processes using WINDOX software. 5 measurements (5.0 g 
samples) were carried out for each granule batch. The QICPIC system is capable of 
measuring particles in the size range of 1 - 34000 μm. The volume-weighted particle 
size distributions and the D10, D50 and D90 values were obtained.  
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3.3.6 Tableting 
The second processing parameter that was varied and examined in this 
research was the tableting stress. This is the second stress which is applied to a 
material during the manufacture of tablets. 
Tablets were produced using an Instron 3367 (Buckinghamshire, UK) with a 
purpose-built flat face upper punch and stationary 12 mm die. Approximately 500 
mg of granules were weighed and filled into the die manually (see Figure 3.5). The 
material was compressed using a loading rate of 1 mm/s, with no dwell time 
following compression. Magnesium stearate was used as an external lubricant 
during tableting to prevent sticking. Tablets were produced using 5 and 20 kN to 
ensure that the tablets exhibited varying properties. This ensured that tablets with a 
range of tensile strengths and porosities were formed for analysis. 
Figure 3.5 Diagram showing compression of granules into a tablet. 
The stress applied during tableting was also calculated by dividing the force 
by the area of the tablet. 
Granules 
Compression Upper punch 
Tablet die 
Tablet 
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Table 3.5 The values for the force used during tableting, and the equivalent stress. 
3.3.7 Tablet tensile strength 
Tablet tensile strength (σT) was calculated using Equation 3.8 (Fell and 
Newton, 1968), by measuring the force required to break the tablet (Fmax). The Fmaz 
was determined using the Zwick-Roell (Ulm, Germany) instrument. The tablet 
dimensions were measured using a precision slider calliper. 
𝛔𝐓 =  
𝟐𝐅𝐦𝐚𝐱
𝛑𝐃𝐓
 
Equation 3.8 
where σT is the tablet tensile strength, D is the tablet diameter and T is the tablet 
thickness.  
3.3.8 X-ray tomography 
X-ray tomography was utilised to determine ribbon and tablet porosity. A 
SCANCO Medical MicroCT35 X-ray (SCANCO, Switzerland) was used to obtain X-
ray images. For ribbons a section of ribbon of 10 mm length was obtained and X-ray 
measurement was carried out at the centre of the ribbon. For tablets the middle of a 
12 mm tablet was scanned. To determine the porosity the images obtained were 
analysed using ImageJ software. By using ImageJ the grey value histograms for 
blank X-rays (which contained only air) and the sample X-rays were extracted, 
Tableting force (kN) Tableting stress (MPa) 
5 44.2 
10 88.4 
20 176.8 
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where 0 is the darkest possible shade (i.e. black). For the blank air measurement the 
histogram for the grey level was calculated to reflect the percentage of the total 
counts. It was assumed that at 99.9 % of the total, the grey level is air and anything 
above is particulate. By using the grey level value obtained as being air, the porosity 
was calculated. 
3.4 Results and Discussion 
3.4.1 Ribbon porosity 
X-ray tomography was utilised to measure ribbon porosity. Porosity is an 
indication of the percentage of air present in a solid system. Ribbon porosity was 
examined to determine the effect of compaction stress at the granulation stages on 
ribbon porosity.  
 
Figure 3.6 Ribbon porosities calculated for Man100:MCC0, Man75:MCC25, 
Man50:MCC50, Man25:MCC75 and Man0:MCC100 ribbons which were produced using 
20 or 100 bar roller compaction pressure. 
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The porosities for ribbons produced using Man100:MCC0, Man75:MCC25, 
Man50:MCC50, Man25:MCC75 and Man0:MCC100 formulations were determined. 
Figure 3.6 shows the ribbon porosities when RC pressures of 20 or 100 bar are used 
during granulation. Man100:MCC0 ribbons are the least porous in terms of the 
material used. When a higher RC pressure is used the ribbons were found to be less 
porous. This is due to the higher stress being applied to the material causing higher 
densification of the material. 
3.4.2 Granule size distribution  
The size distributions for mannitol granules and MCC granules, produced 
using varying roller compaction (RC) pressures, are shown in Figure 3.7 and Figure 
3.8, respectively. Firstly, it can be seen that in every case a bimodal particle size 
distribution was attained. For both MCC and mannitol granules a low RC pressure 
of 20 bar led to a higher percentage of smaller granules than a when a high RC 
pressure (100 bar) is used. Additionally, a higher RC pressure produced a higher 
percentage of larger granules than when a lower RC pressure is used. In the case of 
mannitol granules, the increase of RC pressure led to the size distribution shifting 
towards a unimodal distribution as the percentage of smaller particles decrease 
significantly with the addition of a higher RC pressure and consequently better 
compaction of the powder.  
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Figure 3.7 Granule size distribution data for mannitol granules produced using roller 
compaction at various pressures. 
 
Figure 3.8 Granule size distribution data for MCC granules produced using roller 
compaction at various pressures. 
The D10, D50 and D90 values for mannitol granules and MCC granules are 
shown in Figure 3.9 and Figure 3.10, respectively. MCC granules produced using 
roller compaction are generally larger than mannitol granules produced using the 
same conditions. With increasing RC pressure the D10 particle size increases 
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significantly for both MCC and mannitol granules. The D50 and D90 values also 
increase with increasing RC pressure, however not as drastically as the D10 values. 
 
Figure 3.9 D10, D50 and D90 values for mannitol granules produced using roller compaction 
at various pressures. 
 
Figure 3.10 D10, D50 and D90 values for MCC granules produced using roller compaction at 
various pressures. 
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A decrease in the percentage of smaller particles with increasing granulation 
pressure is fundamentally due to the application of stress to the primary powder 
leading to the formation of bonds. With the application of higher stress stronger 
bonds are formed and the material is more densified during the production of 
ribbons (Khorasani et al., 2016). When the ribbons are then crushed to form 
granules, ribbons produced with higher RC pressure form larger granules and less 
fines due to the strong bond formation. Ribbons produced with less RC pressure are 
weaker and produce more fines during the compaction process and then 
additionally more fines during the crushing process. 
3.4.3 Tablet compactibility  
Compactibility graphs are shown (Figure 3.11) for the tablets produced from 
granules roller compacted using 20 and 100 bar, and tableted using force of 5 and 20 
kN. At a low tableting force (5 kN) the effect of RC pressure is more pronounced in 
terms of the tablet porosity, whereas the tensile strength of the tablets is not 
changing as significantly. Higher RC pressures led to tablets with a lower porosity 
and lower tensile strength.  
To explain these trends the properties of the granular material must be 
considered. A higher RC pressure used during granulation means the material 
undergoes higher stress and therefore forms stronger intra-granular bonding 
(compared to material granulated using a low RC pressure). Therefore, the resultant 
granular material is dense (see Figure 3.6). The application of low stress during 
tableting means that the tablet is unable to form strong particle-particle bonding as 
the granular material is not able to be crushed; the stress is insufficient (see Table 
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3.4). The lower porosity of tablets containing high RC granules may be an indication 
of the granular porosity. This will be examined further in the following Section.  
 
Figure 3.11 Compactibility graph for tablets produced using varying ratios of mannitol 
and MCC, using either 20 or 100 bar RC pressures and using 5 kN tableting force. 
At a 20kN tableting force the porosity and tensile strength also decreased 
when increasing the RC pressure (see Figure 3.12). Granules produced using higher 
RC stress can withstand even higher tableting stresses due to the granular material 
itself being stronger. This may be why the higher RC granules produce weaker 
tablets even at higher tableting forces. Previously in literature this phenomenon has 
been attributed to the “loss in compactibility” of a material, i.e. due to the work 
hardening of a material during granulation.   
The effect of tableting force is evident (see Figure 3.11 and Figure 3.12); a 
higher tableting stress leads to a lower tablet porosity and a higher tablet tensile 
strength, as seen in the literature (Razavi et al., 2016, Schmidtke et al., 2017, 
Hadžović et al., 2011). This is fundamentally due to the further densification of the 
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granular material during the application of the tableting stress, which leads to a 
lower tablet porosity and stronger particle-particle bonding.  
 
Figure 3.12 Compactibility graph for tablets produced using varying ratios of mannitol 
and MCC, using either 20 or 100 bar RC pressures and using 20 kN tableting force. 
In the case of the MCC percentage, the tablet tensile strength increases with 
increasing MCC in all cases (see Figure 3.11 and Figure 3.12). The increase in tablet 
tensile strength is more prominent with increasing tableting force, for a given RC 
pressure with increasing MCC in the formulation. This may be due to MCC ribbons 
being significantly more porous than mannitol ribbons (see Figure 3.6), therefore the 
stress applied during tableting is able to crush more of the granular material which 
contains a higher percentage of MCC and form stronger inter-particle bonding. At 
low tableting load, increasing MCC percentage causes the tablet porosity to 
increase. This will be examined further in the next Section. 
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3.4.4 Tablet internal structure 
The compactibility graphs established that the amount of stress applied to the 
material during roller compaction affects the granular properties. The granular 
properties in turn affect the tablet properties, depending on whether the tableting 
stress applied is higher or lower than the granulation stress. The internal structure 
within the tablet is a key feature which will validate the findings previously 
outlined. The internal structure gives indication of the bonding occurring within a 
tablet, depending on the material and stressed applied at each stage. By using X-ray 
tomography it was possible to visualise the granular material within the tablets and 
determine to what extent the granular structure is maintained during the tableting 
process. The black colour within the X-ray images signifies the presence of air and a 
stronger white colour signifies the presence of material.  
From the images (Figure 3.13) it can be observed that at low tableting force (5 
kN) the Man100:MCC0 granular material is still visible within the tablets, to varying 
degrees depending on the RC pressure used to produce the granule. A higher RC 
pressure during granulation leads to the formation of less porous granule (see 
Figure 3.6); from the X-ray it can be observed that the high RC stress granular 
material integrity is still maintained after the tableting stress is applied. This is due 
to the tableting stress applied to the material being insufficient to crush the granular 
structure (see Table 3.4 and Table 3.5). On the other hand, a low tableting force 
applied to granules produced using a low RC pressure led to a high percentage of 
the relatively weak granular material within the tablet being crushed. The 
equivalent tablet stress was higher than the stress applied during RC, therefore 
more of the granular material is likely to be crushed.  
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In Figure 3.11 the effect of RC pressure was evident in only the tablet porosity, 
with higher RC pressure producing tablets with lower porosity. The X-ray evidence 
suggests that the granular structure within a tablet dominates the overall measured 
tablet porosity. When a high RC stress granule is present and the tableting stress is 
low then the granular structure is prevalent within the tablet and the bonding 
within the tablet is weak. Therefore, the tablet contains low porosity granules and 
pores between the granules (see Figure 3.13). But due to the nature of the X-ray 
measurement, which is carried out on the whole tablet, the average of the granular 
porosity and the inter-granular porosity within the tablet is considered as the total 
tablet porosity. So tablets visibly containing low porosity granules are also 
calculated as having a low tablet porosity.  
The compactibility graphs (see Figure 3.11) also showed that when higher RC 
stress granules are tableted using a low stress, the consequent tablets are more 
porous and also weaker than when low RC stress granules are used. The X-ray 
suggests that this is due to the low RC stress granular material being more readily 
crushed, therefore providing a higher surface area for bonding. Whereas the low 
tableting stress is not sufficient to crush the higher RC stress granules or form strong 
inter-granular bonding. 
With increasing MCC percentage in the tablet, there appears to be an increase 
in the pores which exist in the tablet (see Figure 3.13). This may explain the higher 
tablet porosity witnessed in the previous Section (see Figure 3.11). The porosity was 
measured using X-ray; therefore an average of the tablet granules and pores which 
exist in the tablet were observed. 
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Figure 3.13 X-ray tomography images of tablets with varying ratios of mannitol and MCC, 
which were compacted using 5 kN tableting force and 20 and 100 bar RC pressure 
granules. The images presented were obtained from the centre of the tablet and the colour 
altered for the purpose of presentation to highlight any variation in the internal densities. 
Examples of the granular material and pores present within the tablet are highlighted. 
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When the tableting force is increased to 20 kN (see Figure 3.14), the X-ray 
images for tablets produced using granular material of a low RC pressure (20 bar) 
show that no granular material is present after tableting. This suggests that the 
tableting stress is not only high enough to crush the relatively weak granular 
material, but also high enough to promote strong bonding within the tablet (see 
Table 3.4 and Table 3.5). From the compactibility graphs (see Figure 3.12) it was 
observed that the tablet tensile strength was dependent on the RC pressure used to 
produce the granules, whereas the tablet porosity was largely unaffected. The X-ray 
imaging suggests that at higher tableting force the granular material is 
predominantly crushed, meaning a larger surface area is available for particle-
particle bonding. The compactibility graphs confirm that the low RC pressure in 
addition to a high tableting force leads to the production of the densest and 
strongest tablets.  
In the case where a high RC pressure of 100 bar is used during granulation, a 
high tableting force of 20 kN is still insufficient to crush all granular material (see 
Figure 3.14); in some cases granular material is still visible. At higher tableting force, 
granules produced using a higher RC stress form tablets which are weaker than 
tablets containing low RC stress granules (Figure 3.12), possibly due to the lower 
surface area available for strong inter-granular bonding to occur.  
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Figure 3.14 X-ray tomography images of tablets with varying ratios of mannitol and MCC, 
which were compacted using 20 kN tableting force and 20 and 100 bar RC pressure 
granules. The images presented were obtained from the centre of the tablet and the colour 
altered for the purpose of presentation to highlight any variation in the internal densities. 
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From the X-ray imaging it is clear that the granular porosity greatly influences 
the tablet porosity when low tableting stresses are used. The presence of dense 
granular material after tableting leads to denser tablets, and inversely the presence 
of porous granular material leads to more porous tablets (see Figure 3.11 and Figure 
3.12). It should be noted that tablets containing 100 bar granules were measured to 
be less porous due to the granular material being denser. However, the pores 
between the 100 bar granules are significantly larger than for 20 bar granules. On 
contact with water these pores will allow for rapid uptake of water deep within the 
tablet, even though the calculated porosity is lower. 
The findings in this Chapter are a divergence from what is reported in 
literature which state that the reduction in tensile strength, or “loss in 
compressibility”, when a higher RC pressure is used is due to “work hardening”. 
The literature suggests that the work hardening increases with increasing particle 
size from the same ribbon, i.e. the same density (Herting and Kleinebudde, 2008, 
Mosig and Kleinebudde, 2015, Perez-Gandarillas et al., 2016). The X-ray images 
suggest that the tablet tensile strength is based on whether the tableting stress is 
sufficient enough to crush the granular material, and then form strong particle-
particle bonding (see Figure 3.15). This is dependent on the porosity of the granular 
material. 
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Figure 3.15 Schematic of granule packing after tableting depending on the roller 
compactor pressure. 
3.5 Conclusions 
From this research it was found that tablet compactibility is dependent on the 
RC stress to varying degrees, depending on the tableting stress used to compact the 
granules (see Figure 3.15). At low tableting stress the tablet properties are 
dominated by the granular properties in terms of strength and porosity. This is 
because the tableting stress is insufficient to crush the granular material, which then 
still exists within the tablet and influences the tablet porosity.  
 When a higher tableting stress is used the 20 bar granular structure within a 
tablet was in most cases eliminated. Generally, a significant increase in the tablet 
tensile strength was observed, and the tablet porosity was found to be largely 
unaffected by the RC pressure used. A decrease in tablet tensile strength was 
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observed when higher RC pressure granules were used. In literature this is termed 
as “loss in compressibility” of a material due to compaction of the material during 
the granulation stage. In this research it was proposed that the reduction in tensile 
strength is related to whether the tableting stress is sufficient enough to firstly break 
the granular material, and secondly form strong particle-particle bonding.  
Generally, the addition of MCC caused the tablets to increase in tensile 
strength, to varying degrees depending on the RC stress and tableting stresses used. 
At low tableting stress the porosity increased with increasing MCC percentage in 
the mixture. 
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Chapter 4. LIXELL 
Particle Imaging and 1H 
NMR 
4.1 Introduction 
This chapter will explore modified methods to monitor tablet disintegration 
and dissolution. The standard USP disintegration analysis method (as described in 
Section 1.3) is only able to determine the disintegration time as a singular time point 
at the end of the process. No additional information is obtained regarding the 
processes which occur during the break-up of the tablet into smaller particles, which 
lead to the fully disintegrated tablet.  
Wilson et al. established a particle imaging analysis technique to monitor 
particle release during disintegration (Wilson et al., 2012). A standard USP 
dissolution bath was modified so that the disintegration media could be analysed 
during the disintegration process, with the addition of a commercially available 
particle characterisation equipment. The set-up is based on the disintegration 
medium being pumped through the QICPIC LIXELL particle sizing equipment in a 
closed system. By doing this the particle size and number can be obtained for the 
released particles in the disintegration medium.  
The QICPIC LIXELL method will be used in this Chapter to monitor tablet 
disintegration as it is capable of extracting further information regarding the 
mechanisms occurring during tablet disintegration. Previously, the method was 
LIXELL Particle Imaging and 1H NMR 
88 
 
used to analyse tablets containing an unspecified pharmaceutical formulation 
(Wilson et al., 2012). The formulation was wet granulated and tableted to produce 
tablets with varying properties. In this research dry granulation will be used to 
granulate binary mixtures of a brittle and a ductile material.  
In industry, USP tablet dissolution analysis is determined on-line by the 
utilisation of conductivity or UV spectroscopy, depending on the compound being 
analysed. While these measurements are able to determine the release with time, 
problems arise when multiple soluble and detectable compounds exist. In the case 
of tablet dissolution measurements via conductivity, it is not possible to guarantee 
that the conductivity is caused by a single component within a tablet. There may be 
two or more soluble conductive components or some impurities within the tablet 
which may cause inaccurate readings to be obtained regarding the dissolution of a 
specific compound. UV measurements are able to produce spectra which can be 
used to identify specific compounds within the tablet and determine the 
concentration in solution at a given time. However, if more than one compound is 
present within the tablet with similar spectra, then some overlap may occur, 
meaning that the identification of one compound becomes more difficult. 
In this research 1H NMR will be employed, in addition to the LIXELL particle 
analysis system, as an off-line dissolution analysis method. 1H NMR is commonly 
used as a characterisation method to determine the structure of a compound. The 
technique relies on the protons in a compound imparting peaks that are specific to 
the positioning and the number of protons present. By analysing the chemical shifts 
of the peaks and the spin-spin couplings it is possible to determine the exact 
structure of a compound. This method is more accurate than the commonly used 
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methods to measure tablet dissolution, as soluble compounds are able to be 
independently identified with confidence (Coombes et al., 2014, Wren et al., 2017).  
By observing the particle release during disintegration with time in addition 
to the off-line dissolution analysis, it will be possible to monitor disintegration and 
dissolution simultaneously. It will be determined whether it is possible to detect the 
effect of variation in formulation and processing parameters on tablet disintegration 
and dissolution by using these methods.  
4.2 Materials 
The details of the placebo binary mixtures of mannitol and MCC which will be 
analysed in this Chapter are outlined and characterised in Section 3.2. 
4.3 Methods 
4.3.1 Granulation and tableting 
The granulation and tableting methods which were used are outlined in 
Sections 3.3.2 and 3.3.6, respectively. Table 4.1 shows the processing parameters 
used to produce the tablets which were analysed in this Chapter. The roller 
compaction (RC) pressure used to granulate the material was either 20 or 100 bar. 
The tableting force used to compact the granular material into tablets was either 5 or 
20 kN. 
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Table 4.1 Formulations and processing conditions used to produce binary mixture 
granules with abbreviations. 
Abbreviations 
Mannitol 
(%) 
MCC (%) 
Roller compaction 
pressure (bar) 
Tableting 
force (kN) 
Man100:MCC0 100 0 20, 100 5, 20 
Man75:MCC25 75 25 20, 100 5, 20 
Man25:MCC75 25 75 20, 100 5, 20 
Man0:MCC100 0 100 20, 100 5, 20 
 
4.3.2 LIXELL particle imaging disintegration analysis 
A conventional USP dissolution apparatus was linked in a circular loop 
system to a Sympatec QICPIC (Clausthal-Zellerfeld, Germany) particle size analysis 
apparatus (as shown in Figure 4.1). The QICPIC was fitted with the LIXELL liquid 
dispersion unit and a 1 mm width cuvette which the liquid medium flows through 
during analysis. The QICPIC LIXELL system is able to monitor the particle release 
during tablet disintegration. The images were analysed using Windox 5 software, 
and the data were analysed in terms of the cumulative number of released particles 
and mass weighted particle size distributions, including the D10 and D50 values, as 
functions of time.  
900 ml of deionised water was used per experiment, which was maintained at 
37 °C using a Clifton NE4-D thermostirrer (Weston-Super-Mare, UK) and water 
bath. A Heidolph RZR 2020 paddle stirrer (Schwabach, Germany) was used to 
agitate the liquid media using a 75 mm paddle at a speed of 56 rpm. Water was 
pumped around the disintegration set-up at a rate of approximately 10.6 ml/s, using 
a Watson-Marlow 505Di peristaltic pump (Cornwall, UK). The particle number and 
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sizes were measured for 30 sec and the average of those values was recorded. The 
total run time was 10 min for each experiment. 2 tablets were tested for each 
condition, and the average values are presented.  
Figure 4.1 Schematic of USP LIXELL setup. 
It should be noted that the tablet undergoes two significant mechanical 
stresses during LIXELL disintegration analysis. Firstly, the paddle stirrer agitates 
the liquid and may cause breakage of the tablet. Secondly, the pump which 
circulates the liquid may cause further breakage of the tablet and released particles.  
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4.3.3 1H NMR dissolution analysis 
Tablet dissolution was determined by simultaneously removing samples 
during the LIXELL analysis outlined in Section 4.3.2. These samples were analysed 
off-line through 1H NMR analysis on the liquid media. 1H NMR was used at it is a 
characterisation method which is able to distinguish individual compound 
concentrations within a solution (Coombes et al., 2014, Wren et al., 2017). Existing 
methods for dissolution analysis, such as conductivity and UV spectroscopy are not 
as precise in determining individual components when multiple soluble 
components are present, i.e. in a pharmaceutical tablet formulation. In this research 
the dissolution percentage of mannitol will be determined for the various 
formulations. 
Samples of 700 μl for the analysis were removed at varying intervals and 
placed into a 5 mm NMR tube. An initial sample was taken at t = 0 sec which was 
used as a baseline reading. NMR analysis was carried out using a Bruker Biospin 
600 MHz spectrometer (Rheinstetten, Germany) equipped with a 5 mm TCI 
cryoprobe. 1H NMR spectra were acquired at 26.85 °C (300 K) without sample 
rotation and with two prior dummy scans. Twenty thousand points were acquired 
with a spectral width of 10.6 kHz, constant receiver gain, an acquisition time of 1 s, 
and a recycle delay of 1 s. To ensure high sensitivity 32 scans were run for a total 
experiment time of 70 s. Water suppression was achieved using the NOESY-
presaturation pulse sequence (Bruker noesygpprld pulse sequence) with irradiation 
at the water frequency during the recycle and missing time delays. Data were 
processed in Bruker Topspin 2.1 software. Exponential line broadening was applied 
with the LB parameter set to 0.19, baseline correction was applied using the 
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command “ABS” and integrals were directly compared across multiple spectra 
using the “Use lastscale for calibration” functionality. 
4.4 Results and Discussion 
4.4.1 LIXELL 
The LIXELL-QICPIC system is a liquid particle imaging technique which is 
able to determine the size and number of particles in solution. In this case the 
disintegration medium was circulated into the LIXELL equipment and the size and 
number of particles in solution was determined with time. This was done in an 
attempt to better understand the disintegration process depending on the 
formulation used and the stresses applied during RC and tableting. 
Released particle size during disintegration  
The average volume weighted D10 and D50 values for the various binary tablets 
were obtained from the QICPIC LIXELL measurement and are shown in Figure 4.2. 
It should be noted that the margin of error is relatively high for these data points, so 
this trend cannot be confirmed with confidence.  
Firstly, it was observed that Man100:MCC0 tablets released the largest 
particles during tablet disintegration (see Figure 4.2). Mannitol is a soluble material 
which was easily dispersed into the disintegration media. Additionally, MCC is a 
disintegrant, meaning that the material draws water into the tablet which causes it 
to break into smaller fragments. Therefore, the Man100:MCC0 tablets in the absence 
of MCC do not disintegrate as efficiently into smaller particles as the tablets which 
contain MCC. This phenomenon may also be influenced by mannitol primary 
powder being larger in size (see Table 3.1). The particle release depending on the RC 
pressure or tableting force used is not clear due to the high error. 
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Figure 4.2 Average D10 and D50 values for tablets produced using varying formulations 
and processing parameters. Observed using the LIXELL-QICPIC system.  
Tablets which contain a mixture of mannitol and MCC tended to release much 
smaller particles than Man100:MCC0 tablets (see Figure 4.2). The particle release did 
not vary significantly depending on the processing parameters; again the error is 
too high. 
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For Man0:MCC100 tablets, the size of the released particles were higher for 
tablets which were compressed using 20 kN tableting force. Visually, during the 
measurements it was observed that these particular Man0:MCC100 tablets absorbed 
water and in the case of 20 bar RC pressure the tablet swelled and disintegrated into 
very large fragments (see Figure 4.3). In the case of 100 bar RC pressure the tablet 
disintegrated into relatively smaller fragments. In both cases the tablets 
disintegrated into larger fragments, and tended to settle at the bottom of the 
dissolution vessel (see Figure 4.3 and Figure 4.4).   
 
Figure 4.3 Man0:MCC100 tablet produced using 20 bar granules compacted using 20 kN 
tableting force a) during disintegration at the maximum swelled size and b) after the 
disintegration measurement ended.  
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Figure 4.4 Man0:MCC100 tablet produced using 100 bar granules compacted using 20 kN 
tableting force a) during disintegration at the maximum swelled size and b) after the 
disintegration measurement ended.  
Figure 4.5 shows the D10 and D50 values with time for particles that were 
released from Man100:MCC0 tablets, which were obtained using the LIXELL 
system. The tablets were produced using 20 and 100 bar RC pressure and 5 and 20 
kN tableting force. It should be noted that the D10 and D50 values are significantly 
scattered and the error is substantial. Therefore, the trends which may exist cannot 
be accepted with high certainty.  
Overall, the particle sizes for Man100:MCC0 fluctuated drastically throughout 
the disintegration and the error was high. The number of entrained particles, which 
will be examined in the next Section, may provide additional information as to what 
is occurring. The particle size distributions with time are shown in Appendix 1 - 
Appendix 16. 
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Figure 4.5 The change in D10 and D50 values with time for Man100:MCC0 tablets produced 
using a) 20 bar RC pressure, 5 kN tableting force; b) 100 bar RC pressure, 5 kN tableting 
force; c) 20 bar RC pressure, 20 kN tableting force; d) 100 bar RC pressure, 20 kN tableting 
force.  
Figure 4.6 shows the D10 and D50 particle size data for Man75:MCC25 tablets 
produced using varying RC pressure and tableting stresses. Much smaller sized 
particles were released from this formulation compared to Man100:MCC0 tablets. It 
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is possible that larger particles were released initially for 20 kN tablets (Figure 4.6c 
and Figure 4.6d), however the error is very high to validate this. 
 
Figure 4.6 The change in D10 and D50 values with time for Man75:MCC25 tablets produced 
using a) 20 bar RC pressure, 5 kN tableting force; b) 100 bar RC pressure, 5 kN tableting 
force; c) 20 bar RC pressure, 20 kN tableting force; d) 100 bar RC pressure, 20 kN tableting 
force. 
Figure 4.7 shows the released particle sizes for Man25:MCC75 tablets. The 
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0
500
1000
1500
2000
2500
3000
0 200 400 600
P
ar
ti
cl
e
 s
iz
e
 (
μ
m
) 
Time (seconds) 
0
500
1000
1500
2000
2500
3000
0 200 400 600
P
ar
ti
cl
e
 s
iz
e
 (
μ
m
) 
Time (seconds) 
0
500
1000
1500
2000
2500
3000
0 200 400 600
P
ar
ti
cl
e
 s
iz
e
 (
μ
m
) 
Time (seconds) 
0
500
1000
1500
2000
2500
3000
0 200 400 600
P
ar
ti
cl
e
 s
iz
e
 (
μ
m
) 
Time (seconds) 
a b 
c d 
D
10
 D
50
 
LIXELL Particle Imaging and 1H NMR 
99 
 
and Figure 4.7b). A higher tableting force released slightly larger particles 
throughout the disintegration process (see Figure 4.7c and Figure 4.7d). However, 
the error is significant for this data.  
 
Figure 4.7 The change in D10 and D50 values with time for Man25:MCC75 tablets produced 
using a) 20 bar RC pressure, 5 kN tableting force; b) 100 bar RC pressure, 5 kN tableting 
force; c) 20 bar RC pressure, 20 kN tableting force; d) 100 bar RC pressure, 20 kN tableting 
force. 
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Figure 4.8 shows particle release data for Man0:MCC100 tablets. It should be 
noted that a significant percentage of the MCC fragments were unable to be 
pumped into the LIXELL cuvette for analysis. The biggest tablet fragments settled at 
the bottom of the USP vessel which is a phenomenon that is termed “coning” (see 
Figure 4.3 and Figure 4.4). Therefore, it should be taken in to consideration that not 
all 100% of the released particles were able to be analysed by the LIXELL method.  
Application of low RC pressure and low tableting force leads to the tablet 
disintegrating into the smallest size particles (Figure 4.8a). A high RC pressure and a 
low tableting force led to the release of larger particles which fluctuated in size 
throughout disintegration (Figure 4.8b). When a higher tableting stress was used the 
tablets released particles of a much larger size (Figure 4.8c and Figure 4.8d) than 
when a low stress was applied. The tablets produced using low RC pressure 
granules and high tableting stress released the largest particles. But the significant 
error in these results must be considered. 
It was observed that the released particles were large in size throughout the 
disintegration process for Man0:MCC100 tablets. This is likely due to MCC being 
insoluble in water. Overall, Man100:MCC0 tablets were found to release much 
larger particles for every processing parameter. The next Section will explore the 
number of particles released which may offer some explanation for this 
phenomenon. 
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Figure 4.8 The change in D10 and D50 values with time for Man0:MCC100 tablets produced 
using a) 20 bar RC pressure, 5 kN tableting force; b) 100 bar RC pressure, 5 kN tableting 
force; c) 20 bar RC pressure, 20 kN tableting force; d) 100 bar RC pressure, 20 kN tableting 
force. 
Number of entrained particles 
The numbers of entrained particles, i.e. the number of particles released from 
the tablet which exist in the disintegration medium at a given time, were examined. 
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The numbers of entrained particles were detected for each tablet condition by 
pumping the disintegration media into the QICPIC particle imaging system.  
Figure 4.9 shows the number of entrained particles with time for 
Man100:MCC0 tablets produced using 20 and 100 bar RC pressure, with 5 and 20 
kN tableting forces. From Figure 4.5 it was observed that generally larger particles 
were released throughout the disintegration process. By looking at the number of 
particles in Figure 4.9 it can be seen that while the size of the particles were larger, 
the number is significantly lower than the other tablet formulations. This is 
undoubtedly due to mannitol being a soluble material therefore the number of 
particles observed is considerably low, as the material quickly dissolves into 
solution. 
 
Figure 4.9 Number of entrained particles for Man100:MCC0 tablets produced using 
varying processing parameters.  
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Figure 4.10 shows the number of entrained particles with time for tablets the 
containing Man75:Man25 formulation. Firstly, it should be noted that tablets which 
contain any percentage of MCC release much a much higher total number of 
particles than tablets which do not contain MCC. For tablets which contain MCC the 
number of entrained particles increases initially at a fast rate, then a secondary stage 
of particle release is observed where the number of entrained particles continues to 
increase, albeit at a slower rate than exhibited at the initial stage.   
 
Figure 4.10 Number of entrained particles for Man75:MCC25 tablets produced using 
varying processing parameters. 
The 20 bar RC pressure granules and a low tableting force led to the rapid 
release of a high number of particles during the initial stage. From the 
compactibility analysis (see Figure 3.11) it was determined that these tablets were 
the most porous therefore the rapid disintegration is expected as the water 
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after approx. 100 s the number of entrained particles continues to increase, however, 
at a slower rate than the initial stage. The number of entrained particles continues to 
increase, to the highest total value of all of the tablets and at the highest rate, until 
the experiment was terminated. From the compactibility data it was found that the 
tablets are porous and weak (see Section 3.4.3). And from X-ray analysis it was 
determined that the granular material was crushed into smaller particles (see 
Section 3.4.4). Therefore, it can be assumed that weakly compressed small particles 
exist within the tablet, which supports the particle release behaviour observed. For 
the other tablets, the error is too high to comment on any particle release trends. 
Figure 4.11 shows the number of entrained particles with time for 
Man25:MCC75 tablets, which were produced using varying RC and tableting 
stresses. Following the same trend as the Man75:MCC25 formulation, tablets 
produced using 20 bar RC pressure and 5 kN tableting force initially had a rapid 
increase in the number of entrained. Following this at approximately 100 s the 
number of entrained particles continues to increase, to the highest value for this 
formulation of approximately 500000 particles, but at a slightly slower rate than at 
the initial stage. For all other tablets in this formulation group, the number of 
entrained particles increased steadily throughout the measurement.  
20 bar tablets produced using a low tableting force release a higher number of 
smaller particles (see Figure 4.7a and Figure 4.11). Section 3.4.4 established that low 
RC pressure tends to be crushed into smaller particles during the tableting process, 
as the granular material is weaker than when a high RC pressure is used. Therefore, 
during tableting the low force applied was sufficient to break the granular material. 
However from the compactibility graphs (see Section 3.4.3) it can be seen that the 
tableting force is inadequate to produce strong bonds, and therefore the tablet is 
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weaker. Consequently, during the LIXELL analysis the tablet disintegrates rapidly 
due to the tablet being weak and porous. And in conclusion the tablet breaks up 
into a higher number of smaller particles. 
 
Figure 4.11 Number of entrained particles for Man25:MCC75 tablets produced using 
varying processing parameters.  
Tablets produced using 100 bar RC pressure and a low tableting force 
exhibited a slower increase in the total number of entrained particles compared to 
the 20 bar tablets. From Figure 4.7 it was observed that 100 bar tablets release 
slightly larger particles. From Section 3.4.4 it was found that a low tableting force 
was insufficient to crush the granular material. Therefore, it can be concluded that 
the tablet releases a smaller number of larger particles, i.e. granular material, than 
compared with 20 bar tablets.  
Figure 4.12 shows the entrained particles with time for Man0:MCC100 tablets. 
Overall, a lower number of particles than expected were observed. For tablets 
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containing a mixture of mannitol and MCC, a higher percentage of MCC led to a 
higher number of particles. This is due to the percentage of insoluble material 
increasing, therefore, more particles were observed. However, for tablets containing 
only MCC, the number of particles observed was relatively lower. This is due to the 
MCC particles becoming saturated with water and settling at the bottom of the 
disintegration vessel, meaning that a significant percentage of the tablet material is 
unable to be detected. This was especially the case for tablets produced using a high 
tableting force (see Figure 4.3 and Figure 4.4). 
 
Figure 4.12 Number of entrained particles for Man0:MCC100 tablets produced using 
varying processing parameters. 
Visually, 20 bar granules compacted using a high force produced tablets 
which behaved differently during the disintegration process. The tablets appeared 
to absorb water quickly and expanded vertically. The tablet swelled to its maximum 
size by approximately 1 min (see Figure 4.3). However the majority of the material 
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did not readily break into smaller fragments with time and coning was prevalent 
(see Figure 4.3). This explains why such a low number of entrained particles were 
observed for these tablets. Tablets produced using 100 bar granules and a high 
tableting force also swelled vertically with time; however they also readily broke in 
to large fragments (see Figure 4.4). But due to the fragments settling in the vessel, a 
low number of entrained particles were detected. 
The tablets produced using a lower tableting force exhibited similar behaviour 
to the previous formulations; a lower RC pressure led to the rapid release of a high 
number of particles. Tablets containing 100 bar granules released a lower number of 
particles than 20 bar tablets. The 20 bar particles are possibly smaller in size than the 
100 bar tablets (see Figure 4.8a and Figure 4.8b) due to the granule particles being 
weakly bonded together.  
4.4.2 1H NMR dissolution analysis 
Samples were removed from the USP dissolution beaker and analysed using 
1H NMR to determine the relative concentration of mannitol in the solution. 
Man100:MCC0, Man75:MCC25 and Man25:MCC75 tablets produced using varying 
granulation and tableting stresses were analysed. Samples were taken for the NMR 
measurements at varying time intervals and analysed off-line. It must be taken into 
account that as this is an off-line measurement, the time from when the sample was 
taken from the disintegration measurement to the time when the NMR 
measurement is carried out allows for the dissolution of any particles which may 
exist in the solution. So for a measurement taken at a given time, the relative 
mannitol percentage determined by the NMR is an indication of the particles of 
mannitol which have already dissolved at that time, as well as any undissolved 
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particles which would be detected by the QICPIC LIXELL system at the same time 
during the disintegration measurement. 
Figure 4.13 shows the mannitol release profile for Man100:MCC0 tablets. The 
NMR dissolution profile shows that in most cases the mannitol has fully dissolved 
by 300 s. When comparing the NMR dissolution profile and the number of particles 
released (see Figure 4.9), such low overall numbers were released by Man100:MCC0 
tablets that this cannot be related back to the dissolution trends. 
 
Figure 4.13 Relative mannitol release profile for Man100:MCC0 tablets, produced using 
various processing parameters, measured using 1H NMR spectroscopy. 
It can be clearly observed that when a higher tableting force was used, the rate 
of mannitol release was much slower than when a low tableting force was used. 
This is due to tablets produced using a low tableting force having a lower tensile 
strength and higher porosity (see Figure 3.11). This means that the water uptake is 
rapid and a higher number of particles are released during disintegration. A higher 
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number of released particles present a higher surface area for the dissolution of 
mannitol into solution; therefore the dissolution is  quicker for weaker and more 
porous tablets. The variation in the mannitol release depending on the roller 
compaction pressure used for a given tableting force is unclear; the error is too high. 
Figure 4.14 shows the mannitol release profile for Man75:MCC25 tablets. The 
trend in the rate of release depending on the tableting force used is the same for 
Man100:MCC0 and Man75:MCC25 tablets. Tablets produced using a low tableting 
force released mannitol at a faster rate than when a high tableting force was used.  
 
Figure 4.14 Relative mannitol release profile for Man75:MCC25 tablets, produced using 
various processing parameters, measured using 1H NMR spectroscopy. 
Figure 4.15 shows the release profiles for Man25:MCC75 tablets. For this 
formulation the mannitol release varied depending on the RC pressure and 
tableting force used. In this case the tablets containing 20 bar granules released 
mannitol at the fastest rate. From Figure 3.11 and Figure 3.12 it was determined that 
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for Man25:MCC75 tablets the porosity as well as the tensile strength increases with 
increasing RC pressure used. The 20 bar granules tableted using 5 kN force are 
stronger but also more porous than 100 bar granules. Therefore, it can be assumed 
that the influence of the low tablet porosity on the faster tablet disintegration is 
greater than tablet tensile strength. Tablets produced using 20 bar RC pressure and 
20 kN tableting force released mannitol at the slowest rate, due to the tablet being 
the strongest and the least porous.   
 
Figure 4.15 Relative mannitol release profile for Man25:MCC75 tablets, produced using 
various processing parameters, measured using 1H NMR spectroscopy.  
Figure 4.16 shows the relative mannitol release for Man100:MCC0, 
Man75:MCC25 and Man25:MCC75 tablets at 60 s. The tablets were produced using 
20 and 100 RC pressure and 5 and 20 kN tableting force. The relative percentage of 
mannitol in solution at 60 s has been plotted to determine the concentration of 
mannitol in solution depending on the formulation and processing conditions used. 
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It was observed that tablets produced using a lower tableting load produced 
particles at a faster rate. This is likely due to these tablets being weaker and more 
porous. Therefore, water influx into the tablet is more rapid which encourages the 
dissolution process. 
It was observed that for Man100:MCC0 tablets mannitol did not dissolve into 
solution at the fastest rate in any case, which is counter-intuitive. Appendix 17 
indicates that the volume of Man100:MCC0 particles in solution is much higher than 
tablets containing MCC. This suggests that the mannitol is not readily dissolving, as 
the tablet consisting entirely of mannitol released a higher volume of solid particles. 
The LIXELL system observed a much lower volume of particles released from 
tablets containing MCC which suggests more of the soluble material dissolved into 
solution, as confirmed by the NMR dissolution data (see Figure 4.16).  
 
Figure 4.16 The relative mannitol release at 60 s for Man100:MCC0, Man75:MCC25 and 
Man25:MCC75 tablets produced using 20 and 100 RC pressure and 5 and 20 kN tableting 
force. 
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4.5 Conclusions 
In this chapter the effects of tableting force and RC pressure on tablet 
disintegration were examined using a modified USP apparatus which was 
connected to a particle imaging size measurement equipment. This was done to 
determine whether the method is capable of distinguishing the changes in 
formulation and processing parameters. This analysis method has the capabilities to 
determine the size of the released particles and the number of particles entrained 
with time. In conjunction with this, 1H NMR was used to simultaneously measure 
the dissolution of mannitol. 
By using the LIXELL it was possible to observe a difference in the cumulative 
particle release depending on the formulation used, as a higher percentage of MCC 
in the tablet formation was observed to release a higher number of particles. 
However, it was found that for tablets containing varying ratios of mannitol and 
MCC the LIXELL system was unable to precisely determine the effect of the stresses 
used during roller compaction and tableting on the number of particles released. 
This may be due to the mechanical stresses that the method subjects on the tablet 
due to it re-circulating the disintegration medium and due the agitation caused by 
the paddle stirrer. 
Tablets containing MCC released smaller particles than Man100:MCC0 tablets. 
This is due to MCC being a disintegrant. The LIXELL particle imaging method 
presented high error when detecting the released particle sizes, probably due to the 
method being off-line. Therefore, the particles must travel and undergo various 
mechanical stress before detection occurs, meaning that the measurement is 
imprecise and prone to high error.  
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1H NMR was used to determine the dissolution rate of mannitol for the tablets 
which were analysed. Generally, the tablets produced using a higher tableting force 
presented a slower mannitol dissolution rate than when a low tableting force was 
used. It was also found that Man100:MCC0 tablets exhibited the slowest mannitol 
dissolution. This may be due to the volume of the released particles being higher, 
which could suggest that less mannitol is in solution. 
There are numerous factors which influence the rate at which particles are 
released from a tablet and the rate at which mannitol dissolves into solution. This is 
dependent on the formulation and processing parameters used. These factors 
include the tablet porosity, the tablet tensile strength, the number of particles 
released and the size of the particles which can all influence the rate of release. An 
on-line method used to analyse disintegration would be more favourable as it 
would reduce the error which was observed during the LIXELL method. 
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Chapter 5. Flow Cell 
Imaging 
5.1 Introduction 
Previously, in Chapter 4 an “on-line” particle imaging method was utilised for 
tablet disintegration analysis, however it was found to be unsuitable. This was due 
to the mechanical stress the tablet undergoes during the measurement from 
agitation by the paddle stirrer. Additionally, the particles which are released from 
the tablet must travel a significant distance before being detected by the particle 
analysis equipment. So some information is lost in transition and the particle may 
experience further breakage before being detected. Significant error was observed in 
the data obtained from this measurement, therefore a more on-line approach must 
be explored. 
The aim of this Chapter is to gain a better understanding of tablet 
disintegration using an on-line particle imaging approach. A purpose-built Flow 
Cell was employed which is capable of on-line observation of tablet disintegration 
as it occurs, and which is able to visualise and measure the change in tablet area and 
rate of particle release (Mesnier et al., 2013). This additional information, which is 
obtained as disintegration is occurring, could facilitate a better understanding of 
tablet behaviour, and consequently led to more proficient tablet design. 
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5.2 Materials 
The details of the placebo binary mixtures of mannitol and MCC which will be 
analysed in this Chapter are outlined and characterised in Section 3.2. 
5.3 Methods 
5.3.1 Granulation and Tableting 
The granulation and tableting parameters used to produce the tablets which 
were analysed in this Chapter are outlined in Sections 3.3.2 and 3.3.6, respectively. 
Table 5.1 shows the formulations and processing parameters used in this Chapter. 
Man0:MCC100 was not able to be analysed using the Flow Cell due to the tablet 
swelling extensively and not releasing particles with time, therefore a measurement 
could not be taken (see Appendix 19) 
Table 5.1 The formulations analysed and their abbreviations. RC pressure and tableting 
force is also specified. 
Abbreviations 
Mannitol 
(%) 
MCC (%) 
Roller compaction 
pressure (bar) 
Tableting 
force (kN) 
Man100:MCC0 100 0 20, 100 5, 20 
Man75:MCC25 75 25 20, 100 5, 20 
Man50:MCC50 25 75 20, 100 5, 20 
Man25:MCC75 25 75 20, 100 5, 20 
 
5.3.2 Flow Cell disintegration analysis 
A real-time imaging method was used to monitor tablet disintegration of 
various tablets. A purpose-built Flow Cell (shown in Figure 5.1) was used for tablet 
disintegration analysis. The Flow Cell has an inner diameter of 5 cm and a length of 
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15 cm. The Flow Cell contains a mesh platform for the placement of the tablet and a 
viewing window to enable direct imaging of the tablet and the particles which are 
released from the tablet. Tablets were held in place by using Scotch 8 mm circular 
adhesive dots. A mixture of 1 mm and 2 mm glass beads were placed in the lower 
compartment to ensure a more uniform water flow through the cross-sectional area 
of the cell where the tablet is placed. An RS Centrifugal Pump (Northants, UK), 
capable of pumping at 2.8 l/min, was used to pump water using 6 mm tubing from a 
Clifton NE1-8 unstirred water bath (Weston-Super-Mare, UK) which maintained the 
water temperature at 25 °C. The water was introduced into the Flow Cell through 
the lower inlet into the cell and exited through the upper outlet into a basin. This 
ensured that released particles from the tablet were carried away in the same 
direction as the water flow, and could be imaged without being counted twice. A 
Canon (Tokyo, Japan) EOS 1D Mark IV 16 MP camera, fitted with a Canon (Tokyo, 
Japan) MP-E 65 mm macro lens, was used to obtain images at a rate of 1 fps. 
Uniform lighting within the Flow Cell was achieved using an external Zeiss 
(Oberkochen, Germany) 1800 LCD light source to ensure that the objects could be 
viewed clearly.  
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Figure 5.1 Schematic and image of the Flow Cell set-up. 
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A MATLAB (Mathworks Inc., USA) program (see Appendix 18) was utilised 
to process and analyse the images obtained during measurement. Firstly, during 
image processing the images are thresholded to produce a binary image, with 
objects (tablet and particles) having a value of 1 and background pixels a value of 0. 
Objects within the binary images are identified by detecting collections of pixels 
with a value of 1; with the largest collection being identified as the tablet and the 
remaining being identified as released particles. The 2D tablet area is calculated by 
counting the number of pixels within this area and relating it to the image scale 
calibration. The number of particles released with time is obtained by totalling the 
number of pixel clusters. 
With this method 3 tablets were tested per processing condition, and an 
average of the 3 measurements was analysed. One data point per second was 
obtained during the measurements; to smooth the data a Savitzky Golay Filter 
(Savitzky and Golay, 1964) was applied. A Savitzky Golay Filter applies a moving 
polynomial fit, much like a moving average, to smooth noisy data. In this case a 
subsample distance of 10 and a polynomial order of 2 was used to smooth the Flow 
Cell data. The camera placement (distance from the Flow Cell), the tablet placement 
and the camera focus were established so that the full tablet was clearly visible and 
focused within the camera viewing window during the entirety of the 
measurement, taking in to account tablet swelling. The water flow rate which was 
used during analysis (2.8 l/min) was selected due to the material MCC requiring a 
high flow rate to effectively carry particles out of the Flow Cell once they become 
saturated with water. With lower flow rates saturated MCC particles were found to 
sink back to the mesh platform. This caused some inconsistencies in the data 
obtained whereby the particles are observed as being part of the tablet structure. 
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It was attempted to connect a conductivity meter to the outgoing water from 
the Flow Cell during a disintegration measurement to determine the dissolution of 
mannitol with time. It was unsuccessful due to the high volume of water used 
during each Flow Cell measurement. The concentration of conductive material was 
unable to build up to a detectable level, therefore conductivity measurements failed.   
Fluid Reynolds number 
The Fluid Reynolds number (Re) was calculated using Equation 5.1 (Rott, 
1990). 
𝐑𝐞 =  
𝛒𝐮𝐃
𝛍
 
Equation 5.1 
where ρ is the density of the fluid (1000 kg/m3), u is the velocity of the fluid at the point 
where the tablet is placed in the Flow Cell (0.023 m/s), D is the diameter of the Flow 
Cell (0.05 m) and μ is the viscosity of the fluid (8.9 × 10−4). 
The Reynolds number was calculated to be Re = 1292, which ensures laminar 
flow within the Flow Cell. 
5.4 Results and Discussion 
5.4.1 Imaging 
The tablet disintegration was monitored using a purpose-built Flow Cell 
which allows for the imaging of tablet disintegration in real-time. Figure 5.2 and 
Figure 5.3 show the images that were captured during the analysis taken at varying 
intervals. The images obtained showed that on contact with water tablets tended to 
swell in size then erode, i.e. decrease in size due to particle release. The extent to 
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which the swelling and erosion behaviour occurs during the tablet disintegration 
process is dependent on the formulation and the processing parameter used. 
 Figure 5.2 shows example images for tablets compacted using a tableting 
force of 5 kN. Tablets containing a higher percentage of mannitol (e.g. Figure 5.2a 
and Figure 5.2b) expand slightly and then disintegrate relatively quickly. This is due 
to the mannitol being a soluble material meaning that tablet material is lost through 
particle release as well as through dissolution.  
With the addition of MCC into the tablet formulation the tablet swelling is 
more pronounced at the 1 s time point; this is characteristic of MCC which tends to 
expand on contact with water. The decrease in the tablet area for tablets containing 
higher percentages of MCC is also slower than tableting containing higher 
percentages of mannitol. 
Additionally, due to the insoluble nature of MCC, it was found that MCC 
becomes saturated with water and dwells on the Flow Cell platform rather than 
being transported and removed with the flow of the water. This means that material 
is remaining in the field of view of the measurement even after tablet disintegration 
may have reached completion.  
When looking at the effect of RC pressure, there is no clear visual difference in 
the swelling or erosion behaviour for tablets produced using a low tableting force 
depending on the RC pressure.  
 
Flow Cell Imaging 
 
121 
 
Figure 5.2 Images taken during Flow Cell analysis of tablet disintegration for tablets 
produced using 5 kN tableting force for a) Man100:MCC0, RC pressure 20 bar; b) 
Man100:MCC0, RC pressure 100 bar; c) Man75:MCC25, RC pressure 20 bar; d) 
Man75:MCC25, RC pressure 100 bar; e) Man50:MCC50, RC pressure 20 bar; f) 
Man50:MCC50, RC pressure 100 bar; g) Man25:MCC75, RC pressure 20 bar; h) 
Man25:MCC75, RC pressure 100 bar. 
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Example images for tablets compressed using a tableting force of 20 kN are 
shown in Figure 5.3. Generally with a higher tableting force the erosion time was 
observed to be prolonged. In other words, the tablet area did not decrease after 
swelling occurred in some cases. It was also observed that the disintegration of the 
tablet was much gradual for tablets compacted using 20 kN; the time taken to reach 
the maximum tablet area after swelling was much longer than the comparable 
tablets produced using 5 kN.  
Notably, tablets produced using 20 bar RC pressure and high tableting force 
were found to disintegrate via a different mechanism to what was seen for tablets 
produced using other parameters. Rather than eroding with time while releasing 
particles, the tablet swelled and separated in the centre region and layers of 
compacted material were visible. For Man100:MCC0 tablets a more curved semi-
circle shape was observed (Figure 5.3a). Following the separation of the tablet into 2 
sections the tablet then dissolves rather than eroding into small particles. This 
suggests that shear planes and/or density distributions exist within the tablet which 
manifests during tableting.  
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Figure 5.3 Images taken during Flow Cell analysis of tablet disintegration for tablets 
produced using 20 kN tableting force for a) Man100:MCC0, RC pressure 20 bar; b) 
Man100:MCC0, RC pressure 100 bar; c) Man75:MCC25, RC pressure 20 bar; d) 
Man75:MCC25, RC pressure 100 bar; e) Man50:MCC50, RC pressure 20 bar; f) 
Man50:MCC50, RC pressure 100 bar; g) Man25:MCC75, RC pressure 20 bar; h) 
Man25:MCC75, RC pressure 100 bar. 
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It can also be observed that tablets produced using granules compacted at 20 
bar RC pressure swelled more significantly than when 100 bar RC pressure was 
used. From the compactibility graphs (Section 3.4.3) it was determined that higher 
stress applied during tableting produces stronger tablets. And from the Flow Cell 
images it was seen that the tablets that have had more stress applied tend to swell in 
size more in size. This is due to the application of higher stress leading to stronger 
particle-particle bonding occurring. So when water intake is much slower and it 
causes significant swelling to occur before the bonding is weakened. When the 
bonding becomes too weakened the bonding begins to break and particles are 
released. 
A common trend which was observed is that the top corners of the tablet 
disintegrated before the centre of the tablet in most cases. This tablet erosion 
behaviour could be due to the water velocity variations at different points on the 
tablet. The edges of the tablet are subjected to a higher velocity of water therefore, 
the edge erode more rapidly than the centre of the tablet (see Figure 5.4). This leads 
to the tablet area shape observed in the images obtained through the Flow Cell.    
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Figure 5.4 Schematic of the water flow and velocity acting on the tablet inside the Flow 
Cell. 
5.4.2 Tablet area and particle release 
The change in tablet area with time (see Figure 5.2 and Figure 5.3) is a visual 
indication of tablet disintegration. The tablet disintegration as observed in the 
imaging method shows that the tablet swells in size, before undergoing a secondary 
stage where the tablet begins to erode and decrease in size due to particle release 
and dissolution. From the images it was possible to detect these changes in tablet 
area and the particle release rate in real-time using a MATLAB program (see 
Appendix 18). The areas were calculated by counting the pixels in the images, then 
they were normalised by dividing the changing tablets areas by the initial tablet 
area.  
Figure 5.5 shows the evolution of the normalised tablet area tablets with time. 
Tablets which were compacted using a low tableting force of 5 kN for varying ratios 
of mannitol and MCC granulated at 20 and 100 bar RC pressure are shown. As 
previously observed in the images which were presented in Figure 5.2, the tablet 
first swells to a maximum area. Then the tablet begins to erode due to particle 
High 
water 
velocity 
Low 
water 
velocity 
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release and dissolution. For tablets produced using 5 kN tableting force, the effect of 
variation of the RC pressure was not able to be observed. Tablets containing both 20 
and 100 bar granules swelled and disintegrated in a similar manner, despite the fact 
the tablet porosities varied significantly (see Figure 3.11).  
Figure 5.5a shows that disintegration is rapid for Man100:MCC0 tablets. 
Swelling of the tablets reached a maximum at approximately 20 sec. Erosion after 
swelling also occurs relatively rapidly, with tablet area reaching near 0. When the 
percentage of MCC within the formulation is increased the tablet swelling was 
comparable to Man100:MCC0 tablets.  
Generally the addition of MCC was found to prolong the disintegration time. 
In other words, the tablet does not erode meaning that the tablet area does not 
decrease as readily. With the addition of MCC into the formulation the 
disintegration stage after swelling is less pronounced. For tablets containing any 
amount of MCC the tablet area does not decrease as quickly as tablets containing 
only mannitol. Tablets which contain 50% or more MCC do not exhibit a decrease in 
tablet area below the original area; this is due to the MCC becoming saturated with 
water and resisting being carried away with the water flow. 
It should be noted that for Man0:MCC100 tablets was it was not possible to 
carry out the Flow Cell analysis as the tablet swells significantly but does not change 
in area following the swelling stage (see Appendix 19). Particles are also not 
released and therefore Man0:MCC100 tablets were deemed to be not viable for 
measurement using the Flow Cell.  
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Figure 5.5 The change in the normalised tablet area with time for tablets with varying 
ratios of mannitol and MCC granules which were produced using RC pressure of 20 and 
100 bar and a tableting force of 5 kN. 
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Figure 5.6a shows the cumulative number of released particles with time for 
tablets produced using 20 and 100 bar RC pressure granules which were compacted 
at 5 kN tableting force. Man100:MCC0 tablets (Figure 5.6a) released particles in a 
similar manner independent of the RC pressure used; initially there is a period of 
rapid particle release, followed by a period of slower particle release. The effect of 
RC pressure is not apparent for Man100:MCC0 tablets, which was also the case for 
the change in tablet area with time.  
Man75:MCC25 tablets produced particles at a similar rate to Man100:MCC25 
tablets. A slight difference was observed in the rate of release of particles depending 
on the RC pressure used. 20 bar granules appeared to release particles at a faster 
rate; however the error is high in this data to confirm this with certainty.  
Tablets containing a high percentage of MCC (Figure 5.6c and Figure 5.6d) 
which were produced using 20 bar RC pressure granules also appeared to release 
particles at a faster rate than the equivalent 100 bar granule tablets. This difference 
in release rate is more pronounced for tablets containing MCC as it is an insoluble 
material; therefore observation of a higher number of overall particles is more likely. 
However, it must be taken into consideration that the error in some cases is 
significant, therefore there is some uncertainty in the data.  
From the X-ray measurements (see Section 3.4.4) it was observed that the 
tableting stress being applied in this case sufficient to crush a significant amount of 
the 20 bar granules, causing a larger number of weakly bonded smaller particles to 
be present within the tablet. The Flow Cell data supports this as the tablets 
produced using 20 bar granules appear to release a greater total number of particles. 
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Figure 5.6 The total number of released particles with time for tablets with varying ratios 
of mannitol and MCC granules which were produced using RC pressure of 20 and 100 bar 
and a tableting force of 5 kN. 
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The change in tablet area with time for tablets compacted using a higher 
tableting force of 20 kN are shown in Figure 5.7. At 20 kN tableting force, the 
Man100:MCC0 tablets disintegration was highly dependent on the RC pressure 
used (see Figure 5.7). With 100 bar RC pressure, the tablets did not swell as highly 
as the 20 bar tablets. The maximum tablet area was also reached at a quicker time 
(2.5 min). Whereas a low RC pressure of 20 bar, the tablets swelled to around 2 
times the maximum tablet area, and reached this area at the slowest time of 5.1 min. 
The overall disintegration time was prolonged due to the higher tableting force 
used.  
In all cases, tablets containing granules produced using 20 kN tableting for 
and 20 bar RC pressure swelled to a higher tablet area than 100 bar. Additionally, 
the overall time taken for the tablet to erode, i.e. decrease in size, to an equivalent 
tablet area following erosion was longer for 20 bar tablets.  
With increasing MCC percentage in the formulation a significantly higher 
tablet swelling was observed. Furthermore, the addition of MCC in the formulation 
led to a prolonged erosion time, which is due to the uptake of water into the MCC 
causing it to become saturated and unable to fully and completely disintegrate (see 
Figure 5.7c and Figure 5.7d). This caused the tablet particles to remain on the 
platform rather than eroding away and decreasing in area. This was especially the 
case for Man25:MCC75 tablets for which no change in tablet area was observed 
between 6 – 15 mins. 
Flow Cell Imaging 
 
131 
 
 
Figure 5.7 The change in the normalised tablet area with time for tablets with varying 
ratios of mannitol and MCC, produced using a tableting force of 20 kN. 
0.0
1.0
2.0
3.0
4.0
5.0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
N
o
rm
al
is
e
d
 T
ab
le
t 
2
D
 
ar
e
a 
Time (min) 
Man100:MCC0 
0.0
1.0
2.0
3.0
4.0
5.0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
N
o
rm
al
is
e
d
 T
ab
le
t 
2
D
 
ar
e
a 
Time (min) 
Man75:MCC25  
0.0
1.0
2.0
3.0
4.0
5.0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
N
o
rm
al
is
e
d
 T
ab
le
t 
2
D
 
ar
e
a 
Time (min) 
Man50:MCC50 
0.0
1.0
2.0
3.0
4.0
5.0
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
N
o
rm
al
is
e
d
 T
ab
le
t 
2
D
 
ar
e
a 
Time (min) 
Man25:MCC75 
a 
b 
c 
d 
20 bar 
100 bar 
Flow Cell Imaging 
 
132 
 
The effect of tableting force on tablet disintegration is quite clear; a higher 
tableting force led to higher tablet swelling and a prolonged erosion time. This is 
due to the material becoming more compacted therefore water intake is slower. And 
due to the higher tableting stress applied the bonding within the tablet is much 
stronger and consequently disintegration is delayed. 
When a higher force of 20 kN was applied to produce the tablets, the effect of 
RC pressure was less apparent in terms of the particle release (Figure 5.8). Generally 
tablets containing granules produced using 20 and 100 bar RC pressure both 
released particles at a similar rate (Figure 5.8a – Figure 5.8c). With the exception of 
Man25:MCC75 tablets (Figure 5.8d) for which 20 bar granules led to a faster particle 
release rate. However, the error in all cases is high and a conclusive difference in the 
particle release depending on the RC pressure used cannot be elucidated from the 
data.  
In terms of the release rate, all tablet formulations released particles at a 
comparable rate. From X-ray analysis of the tablet internal structure it was found 
that when a higher tableting force is used, the granular material largely becomes 
crushed. Tablets containing 100 bar granules showed that the granular structure is 
partially visible (see Figure 3.14), however the granular material is strongly and 
densely bonded. The granular structure no longer has any influence. This supports 
the particle release data as we see similar particle release numbers for each of the 
formulations (see Figure 5.8).  
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Figure 5.8 The total number of released particles with time for tablets with varying ratios 
of mannitol and MCC, produced using a tableting force of 20 kN.  
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5.5 Conclusions 
The Flow Cell analysis of tablet disintegration found that at low tableting 
force the Man100:MCC0 tablets disintegrated in a similar manner regardless of the 
RC pressure used. For tablets containing MCC, a lower RC pressure led to slightly 
more swelling during disintegration. At high tableting force the disintegration 
behaviour for all tablets tested varied depending on the RC pressure used. In all 
cases a lower RC pressure led to more tablet swelling and a slower disintegration 
time. However, the error in the data was relatively high so the trends observed 
cannot be confirmed. 
From the Flow Cell images it was observed that the addition of MCC in the 
tablet formulation leads to higher tablet swelling and a longer disintegration time. 
Similarly, when a higher tableting force was applied to the tablet, the time taken for 
the tablet to swell to the maximum area and then to erode was delayed due to 
stronger bonding within the tablet, therefore water uptake was slower.  
In terms of the particle release, the data suggested that at low tableting force 
the particle release rate was in some cases dependent on the RC pressure used. If a 
low RC pressure was used during granulation, a faster particle release rate was 
observed from the consequent tablets. From the X-ray imaging it was found that the 
weaker granular material is being crushed into a smaller granules and primary 
powder during tableting. This, in addition to the weakness of the tablet, may lead to 
a faster release rate of a higher number of particles for these tablets containing 
weaker granular material.  
At higher tableting force it was found that the particle release is similar for 
both high and low RC pressures. This is due to the stress being high enough to 
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crush the granular material and bond it strongly, in most cases, during tableting. 
Therefore, the particle release rate is slow and the number is almost identical and 
independent of the RC pressure used previously. 
Overall, it was determined that many factors affect the tablet swelling and 
erosion of tablets. The differences observed due to the material properties were 
clear; MCC swelled and prolonged the erosion time, whereas mannitol dissolved 
relatively quickly. The stress applied during tableting and RC also played a part. 
The porosity and bonding within the tablet (i.e. the tensile strength) affected the 
disintegration time how the tablet swelled.  
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Chapter 6. USP vs Flow 
Cell Imaging 
6.1 Introduction 
In the previous Chapters it was determined that the effect of different filler 
excipients on the tablet disintegration was apparent and significant. The aim of this 
Chapter is to compare the Flow Cell, a particle imaging approach, and the 
conventional USP disintegration analysis technique to monitor tablet disintegration 
of a placebo formulation. A placebo formulation contains a mixture of excipients, 
each with a function, but no active pharmaceutical ingredient (API). 
A purpose-built Flow Cell, which was previously explored in Chapter 5, was 
employed which is capable of on-line observation of tablet disintegration. This 
technique can provide information about the changing tablet dimensions and the 
particles released with time. This additional information can improve the 
understanding of how different materials and process parameters affect tablet 
disintegration. Standard USP analysis was also carried out which is able to 
determine the disintegration time (see Section 1.3). It will be evaluated whether the 
USP method can differentiate the disintegration behaviour of tablets produced 
using different formulations and processing parameters. 
In this Chapter a placebo pharmaceutical formulation was analysed to 
investigate which disintegration analysis method is more informative when a tablet 
contains many components, as it would in a pharmaceutical solid unit dosage. It 
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will also be determined which, if any, of the analysis techniques is able to detect 
variation in the formulation, RC stress and tableting stress used. 
6.2 Materials 
In this Chapter placebo pharmaceutical formulations will be examined. The 
excipient materials were used as received, unless otherwise stated.  
6.2.1 Fillers 
Microcrystalline cellulose Avicel PH101 from Sigma Aldrich (St. Louis, USA) 
and Mannitol Pearlitol 200SD from Roquette (Lestrem, France) were used as fillers. 
Further information is provided in Section 3.2.1 and Section 3.2.2. 
6.2.2 Binder 
Povidone Kollindon 30 from BASF (Geismar, Germany) was used as a binder. 
Povidone is a fine, white, hygroscopic powder. Commonly used as a binder with 
both wet and dry granulation to produce solid dosage forms (Rowe et al., 2009).  
6.2.3 Disintegrant 
Sodium starch glycolate from Roquette (Lestrem, France) was used as a 
disintegrant. It is structurally described as a crosslinked carboxymethyl ether of 
starch which disintegrates due to rapid uptake of water and consequent swelling 
(Rowe et al., 2009). It is commonly used in the pharmaceutical industry in various 
oral dosage systems. 
6.2.4 Lubricant  
Magnesium stearate from Mallinkrodt (St. Louis, USA) was used as a 
lubricant.  
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6.2.5 Placebo formulation 
Table 6.1 shows the two placebo formulation analysed in this Chapter, 
containing varying ratios of fillers MCC and mannitol, sodium starch glycolate as a 
rapid disintegrant, povidone as a binder and magnesium stearate as a lubricant. The 
formulations contained either an excess of mannitol or an excess of MCC, hence the 
abbreviated names.  
Table 6.1 The abbreviations for the placebo formulations. 
Materials 
Abbreviations 
Solubility 
in water 
ExMCC ExMan 
Mannitol (%) 15 75  
MCC (%) 75 15  
Sodium starch glycolate (%) 3 3  
Povidone (%) 5 5  
Magnesium stearate* (%) 2 2  
*The full amount of lubricant was added prior to granulation 
6.3 Methods 
6.3.1 Granulation and tableting 
The granulation and tableting parameters used to produce the tablets which 
were analysed in this Chapter are outlined in Sections 3.3.2 and 3.3.6, respectively. 
The three ExMan formulations are outlined in Table 6.2; this is due to the variation 
in the processing parameters. RC pressures of 20 or 50 bar and tableting forces of 15 
or 25 kN were used to produced tablets. 
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Table 6.2 The RC pressures and tableting forces used to produce tablets. 
 ExMCC-A ExMan-A ExMan-B ExMan-C 
RC pressure (bar) 20 20 20 50 
Tableting force (kN) 25 25 15 15 
In this study a comparison of the variation in formulation (ExMCC-A vs 
ExMan-A), variation of the RC pressure (ExMan-B vs ExMan-C) and a variation in 
the tableting force (ExMan-A vs ExMan-B) will be examined. 
6.3.2 Granule size distribution 
The granule size distribution was determined by using the method specified 
in Section 3.3.5.  
6.3.3 Tablet tensile strength and porosity 
Tablet tensile strength was calculated by using the method outlined in Section 
3.3.7. The tablet porosity (εT) was calculated using Equation 6.1 and Equation 6.2 
(Gad, 2008). The true densities of the powders were obtained from the 
manufacturer. The tablet dimensions were measured using a precision slider 
calliper. Tablets were weighed using a Mettler Toledo AE 160 (Greifensee, 
Switzerland). 10 tablets were tested for each batch where either the formulation or 
processing parameter was varied. The average of the 10 values was calculated. 
𝐀𝐩𝐩𝐚𝐫𝐞𝐧𝐭 𝐝𝐞𝐧𝐬𝐢𝐭𝐲 =  
𝐓𝐚𝐛𝐥𝐞𝐭 𝐰𝐞𝐢𝐠𝐡𝐭
𝐓𝐚𝐛𝐥𝐞𝐭 𝐯𝐨𝐥𝐮𝐦𝐞
 
Equation 6.1 
𝛆𝐓 = (𝟏 −
𝐀𝐩𝐩𝐚𝐫𝐞𝐧𝐭 𝐝𝐞𝐧𝐬𝐢𝐭𝐲
𝐓𝐫𝐮𝐞 𝐝𝐞𝐧𝐬𝐢𝐭𝐲
) × 𝟏𝟎𝟎 
 
Equation 6.2 
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6.3.4 USP disintegration analysis 
The disintegration time of the tablets was measured using a Copley ZT74 6 
tablet tester (Nottingham, UK). A mesh size of 2mm square was used and 800 ml 
water heated to 37 °C was used as the disintegration medium. At least 8 tablets were 
tested for each condition. The mean disintegration time of all of the tested tablets, 
and the time taken for the last (slowest) tablet to disintegrate were both recorded. 
Figure 6.1 USP Basket-Rack assembly. 
6.3.5 Flow Cell disintegration analysis 
The Flow Cell apparatus used to monitor tablet disintegration is outlined in 
Section 5.3.2. The MATLAB code used to analyse the obtained images is outlined in 
Appendix 18. At least 5 tablets were tested per condition. In addition to the change 
ion tablet area and the number of particles, the particle size was also calculated by 
using the MATLAB code in Appendix 20. 
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6.4 Results and Discussion  
6.4.1 Granule size distribution 
Figure 6.2 shows the D10, D50 and D90 granule size values for the excess MCC 
formulation and compressed at 20 bar roller compaction pressure (ExMCC-A), and 
the granules produced using the excess mannitol formulation which was 
compressed using 20 and 50 bar roller compaction pressure (ExMan-A and ExMan-
C, respectively). It was found that all of the granules exhibited similar D10 and D90 
values, however the D50 did vary. Firstly, when comparing the effect of formulation, 
ExMan-A granules had a higher D50 value than ExMCC-A granules. 
 
Figure 6.2 Volume-weighted granule D10, D50 and D90 data for the various formulations. 
Secondly, when examining the effect of RC pressure it was found that a higher 
RC pressure led to an even higher D50 value. A higher stress applied during RC 
causes higher densification of the primary powder into stronger granules (Patel et 
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al., 2011). Therefore, ExMan-C granular material is larger in size following 
granulation. 
6.4.2 Tablet tensile strength and porosity 
Figure 6.3 shows the variation in tensile strength and porosity in tablets which 
contain varying ratios of fillers (MCC and mannitol) which have been produced by 
varying the processing parameters (granulation and tableting stress). Firstly, the 
effect of varying the formulation, namely the filler material, will be examined by 
comparing ExMCC-A and ExMan-A tablets. ExMCC-A tablets displayed lower 
tensile strength and porosity than ExMan-A tablets. MCC is a ductile material which 
is highly deformable (Mitra et al., 2016), whereas mannitol is brittle and does not 
deform as easily (Wu and Sun, 2007). Therefore, a lower porosity in tablets 
containing an excess of MCC could occur due to MCC becoming highly deformed 
during application of stress, firstly during roller compaction and then during 
tableting, leading to a decreased in the void space within the tablet. On the other 
hand, mannitol may undergo less deformation during the applications of stress, 
therefore more void space within the tablet remains and consequently higher tablet 
porosity is observed.  
Secondly, the effect of tableting stress on tablet tensile strength and porosity 
was investigated by compacting tablets at higher and lower forces of 25 or 15 kN 
(ExMan-A and ExMan-B, respectively) using the excess mannitol formulation 
granules roller compacted at 20 bar pressure. ExMan-B tablets exhibited a lower 
tensile strength and higher porosity when compared to ExMan-A tablets. It has been 
reported in literature that, for a given material, a tablet with a low porosity can be 
expected to display high tensile strength (Sun, 2005). When a higher stress is applied 
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during tableting, the granular material is more likely to be crushed into smaller 
fragments. Additionally, stronger inter-granular bonding occurs and consequently 
strong tablets are formed. Additionally less void space remains within the tablet 
due to the increased stress leading to greater reduction in the bulk material volume, 
and therefore a lower tablet porosity is observed (Mitra et al., 2016, Wu et al., 2006). 
 
Figure 6.3 The tensile strength σT (± SD) and porosity εT (± SD) of tablets. Granules were 
produced using 20 or 50 bar roller compactor hydraulic pressure; the granules were then 
compressed using a tableting force of 15 or 25 kN.  
Lastly, the effect of stress during granulation on tablet tensile strength and 
porosity was determined. Tablets were produced using the excess mannitol 
formulation granules produced using 20 and 50 bar ribbon pressure (ExMan-B and 
ExMan-C, respectively) during roller compaction and tableted using a constant force 
of 15 kN. Variation of ribbon pressure has a greater effect on tablet tensile strength 
than tablet porosity. Figure 6.3 shows that ExMan-B tablets and ExMan-C tablets 
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displayed almost identical porosities, however they varied greatly in tensile 
strength. Weaker tablets were produced when a higher pressure was used during 
roller compactor granulation (50 bar). In literature it has been reported that when a 
high stress is applied the deformability of a material decreases which weakens the 
overall structure (Bultmann, 2002). However, from Section 3.4.4 it was determined 
that for binary mixtures the tableting stress applied to the material, and the extent of 
that stress, affects the consequent tablet properties differently depending on the RC 
stress previously applied to the material. So when a higher stress of 50 bar was 
applied during roller compaction, the primary powder is more strongly bonded 
within the granular material than the 20 bar granules. Therefore, a tableting force of 
15 kN is more likely to crush granular material roller compacted using 20 bar 
pressure into smaller fragments with a higher surface area. The tableting force is 
then more likely to cause stronger bonding of those smaller fragments to occur, 
leading to the 20 bar granule tablets being stronger.  
6.4.3 Standard USP analysis 
The disintegration times, which were recorded using the standard USP in-
vitro testing equipment, are given in Table 6.3. From the USP analysis the average 
disintegration time (tavg) and the time taken for the slowest tablet to disintegrate 
(tslow) is able to be determined. In terms of the effect of formulation, the USP analysis 
showed that the ExMCC-A tablets exhibit the longest disintegration time in the case 
of both the mean and slowest tablet disintegration time.  
For the ExMan formulation, when looking at the effect of RC stress the 
ExMan-B and ExMan-C tablets disintegrated at almost identical times, which 
suggests that for this given formulation tablets of the same porosity, regardless of 
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the RC stress applied to the material, will exhibit the same disintegration behaviour. 
When looking at the effect of tableting stress ExMan-A tablets displayed a 
marginally longer average disintegration time than the higher porosity ExMan-B 
tablets; but the tslow for the ExMan-A tablet was faster than the ExMan-B formulation 
tablet.  
It can be observed that for the ExMan formulation the USP apparatus 
indicates that variation in the RC and tableting stresses leads to comparable 
disintegration times in the cases which are examined in this Chapter. There is 
hardly any variation in the disintegration times to distinguish the effect of the two 
stresses. 
Table 6.3 Disintegration data obtained via USP analysis.  
 tavg (min) tslow (min) 
ExMCC-A 11.9 ± 0.5 12.9 
ExMan-A 5.2 ± 0.8 6.1 
ExMan-B 5.1 ± 2.0 8.5 
ExMan-C 5.1 ± 1.6 8.9 
 
6.4.4 Flow Cell analysis  
Imaging 
Examples of the binary images obtained with time during the disintegration of 
a tablet are shown at 10 min intervals in Figure 6.4. By conversion to a black and 
white image, the tablet and particles released from the tablet are more easily 
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detected and quantified. The variation in tablet area, the number of particles 
released from the tablet and the average sizes of these particles were observed and 
quantified using a MATLAB code (see Appendix 18). The code recognises white 
pixels as the tablet and particles and uses these values to calculate the tablet 2D area 
and particle release number. The area was then normalised by dividing the tablet 
area at a given time by the initial tablet area. In the first image at t = 0 min the initial 
tablet can be viewed with no evidence of disintegration. As time proceeds the tablet 
swelling and particle release can be observed. With time erosion of the tablet occurs, 
i.e. particle release and the tablet dissolves, a decrease in the tablet area is visible.  
For ExMCC-A (Figure 6.4) the tablet swells significantly by 20 min, and then 
slowly erodes from the edges (a possible explanation is given in Figure 5.4). This is 
due to the nature of MCC which tends to swell when it absorbs water. In the case of 
the ExMan-A and the ExMan-B tablets (Figure 6.4a and Figure 6.4b) after 20 min the 
tablet size appears to be equivalent. However, a difference in the remaining tablet 
area is more visible in the 20 min image where the ExMan-B tablet has eroded 
further than the ExMan-A. The fastest tablet erosion was observed in the ExMan-C 
tablet (Figure 6.4d) as the image at 20 min shows only a small area of remaining 
tablet after erosion has already occurred.  
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Figure 6.4 Binary images obtained during tablet disintegration at 10 min intervals for 
tablets a) ExMCC-A; b) ExMan-A; c) ExMan-B; d) ExMan-C. 
Effect of filler content  
The effect of varying the filler content was examined in terms of the change in 
tablet area and the number of particles released with time (see Figure 6.5). Both 
batches of granules were produced by using 20 bar hydraulic pressure to compress 
the powder material via roller compactor granulation. A tableting force of 25 kN 
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was used to compact granules from the ExMCC and ExMan formulations 
respectively into tablets.  
 
Figure 6.5 a) 2D tablet area vs time during the disintegration of tablets produced using 
granules compressed at 20 bar hydraulic pressure in a roller compactor. A tableting force 
of 25 kN was used to compact the excess MCC and excess mannitol granules, respectively; 
b) the number of particles released for the aforementioned tablets. 
Tablets containing an excess of MCC (ExMCC-A) swelled to the maximum 
tablet area after 24 min. This is considerably delayed when compared to the tablet 
containing excess mannitol (ExMan-A) which swelled to the maximum tablet area at 
5 min. ExMCC-A tablets also swelled to a higher maximum tablet area than ExMan-
A tablets. This is attributable to MCC having an inherent affinity for absorbing more 
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water than the available void space, causing the material to swell significantly 
(Ferrari et al., 1996).  
ExMCC-A tablets also exhibited slower overall erosion time, i.e. reduction in 
tablet area, and released a greater number of particles than the ExMan-A tablets. 
ExMCC-A tablets were less porous than ExMan-A tablets which may prolong the 
disintegration timescale. It may also be suggested that higher tablet expansion could 
be due to slow water uptake, which leads to slow tablet breakage and therefore slow 
particle release. If the particles and granule within the tablet are strongly bonded 
together then, following the water uptake, the time taken for the bonding between 
the tablet materials to break may be slow. This in turn allows for more extensive 
tablet swelling to occur before particles begin to break away from the tablet. 
Additionally, mannitol is a highly soluble material, this factor may have influenced 
the faster disintegration observed in tablets containing an excess of mannitol. This is 
also supported by the standard USP analysis data (Table 6.3) which determined that 
the ExMan-A tablets disintegrated twice as fast as the ExMCC-A tablets. However, 
by using the Flow Cell method it was possible to determine that the ExMCC-A 
tablets swelled extensively, but in this case this did not mean that the tablet 
disintegrated more quickly. In actuality the tablet took longer to decrease in tablet 
size, and the particle release was comparable for both formulations. 
The rate of particle release for both of the formulations appears to be almost 
identical. It should be taken into account that ExMan-A tablets contain a higher 
percentage of soluble material, so a lower number of particles were expected to be 
released. The size of the particles released may instead be larger in size for ExMCC-
A tablets.   
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Effect of ribbon pressure 
Tablets were produced using 15 kN tableting force, containing excess 
mannitol granules which were roller compacted (RC) at either higher pressure (50 
bar) or lower pressure (20 bar). The tablets were examined to determine the effect of 
RC pressure on tablet disintegration (see Figure 6.6). Tablets made using granules 
compressed at 50 bar roller compaction pressure (ExMan-C) swelled to a higher 
maximum area than tablet produced using 20 bar pressure (ExMan-B). Both ExMan-
B and ExMan-C tablets reached the maximum swelling area in approximately 2 min. 
Following the maximum area, the tablets erode at approximately the same rate.  
Previously it was established that the two batches of tablets in question had 
almost identical porosity values, and only varied in tensile strength (see Figure 6.3). 
It can be suggested that the tablet swelling is related to how strongly the tablet is 
bonded, that tablet erosion is dependent on tablet porosity since the tablets 
produced by compressing the 20 and 50 bar granules had similar porosities. The 
results from the USP testing are in agreement with this as it also determined that the 
disintegration times for these tablets were almost identical (Table 6.3).  
The tablets did vary in the particle release. The particle release rate was found 
to be slightly slower for the ExMan-C tablets than the ExMan-B tablets. However, 
the error was a little high so the trend is not clear. The size of the released particles 
may again play a role. The particles released from the tablets made using 20 bar are 
perhaps smaller in size than in the 50 bar, but more particles are observed overall.  
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Figure 6.6 a) 2D tablet area vs time during the disintegration of tablets produced using 
granules compressed using 20 and 50 bar roller compactor pressure, compacted at a 
tableting force of 15 kN. b) The number of particles released for the aforementioned 
tablets.  
Effect of tableting force  
Tablets were produced using the excess mannitol formulation by compacting 
20 bar granular material using either 15 or 25 kN tableting force to determine the 
effect of varying tableting force. A significant difference was not observed using the 
USP standard disintegration testing equipment (Table 6.3). But by using the Flow 
Cell method the change in the 2D tablet area with time (see Figure 6.7) showed that 
ExMan-A tablets swelled slightly more and at a slower rate than the ExMan-B 
tablets. The same granular material was used for tableting; therefore, it can be 
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assumed that the variation in the extent of swelling is due to the compaction force 
used during tableting and the consequent tablet tensile strength and porosity 
values. The ExMan-A tablets swelled in size to a greater extent, but the time take to 
reach the maximum swelling area was also greater. The erosion of the tablet, i.e. the 
reduction in size of the tablet, following swelling was also delayed for ExMan-A 
tablets. This may be due to the bonding within the tablet being stronger and 
therefore the time taken for these bonds to break following water uptake may be 
delayed. This leads to significant tablet swelling, due to the MCC expanding 
following water absorption, before the tablet begins to decrease in area. This may 
also be a relaxation phenomenon where a greater change in the tablet area is seen 
following a greater stress applied during tableting.  
Faster disintegration times were observed with ExMan-B tablets, and 
correspondingly a faster particle release rate. A slower particle release was seen in 
the case of the less porous ExMan-A tablets. In addition, the overall number of 
particles released at a given time was lower for the ExMan-A tablets. A possible 
reasoning for this phenomenon could be due to the slower tablet disintegration and 
release of the particles in these tablets; the soluble materials within the particles may 
dissolve into solution before being detected by the imaging method and therefore 
fewer particles are observed. 
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Figure 6.7 a) 2D tablet area vs time during the disintegration of tablets produced using 
granules compressed using 20 bar roller compactor pressure, compacted at a tableting 
force of 25 or 15 kN b) The number of particles released for the aforementioned tablets.  
Size of released particles 
In addition to being able to detect the tablet area and the number of particles 
released with time, the Flow Cell is also capable of monitoring the size of the 
released particles. However, the error for these data points was also quite high, as 
also seen with the LIXELL measurement (see Section 4.4.1).  
The D10, D50 and D90 values for ExMCC-A tablets with time are shown in 
Figure 6.8. Overall, the ExMCC-A tablets released the largest particles throughout 
the disintegration. This is due to the high percentage of MCC. MCC swells on 
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contact with water and is insoluble in water; therefore the Flow Cell method 
detected the release of the swollen MCC particulate.  
 
Figure 6.8 Average D10, D50 and D90 values for the particles released from the tablets with 
time. 
When considering the effect of variation in the formulation ExMan-A tablets 
released smaller particles than the ExMCC-A tablets. This may be due to the lower 
percentage of MCC in the formulation, meaning that the percentage of larger 
swollen MCC particles being detected is lower. From Figure 6.5 it was observed that 
the number of particles released was almost identical for ExMCC-A and ExMan-A 
tablets therefore the size of the particles is likely due to the increased MCC content 
in ExMCC-A tablets. 
When comparing the effect of RC pressure, ExMan-C tablets released slightly 
smaller particles than ExMan-B. From Figure 6.6 it was determined that the number 
of particles releases was also slightly higher for ExMan-B tablets which was not 
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expected. For these conditions it was expected ExMan-C tablets would release a 
lower number of larger particles due to the granules being larger in size and the 
tableting stress being insufficient to crush and bond them. However a lower number 
of slightly smaller particle were release, therefore this may be experimental error or 
there is another factor at play. 
When considering the effect of tableting force on the size of the particles 
released, the ExMan-B tablets released larger particles than the ExMan-A tablets. 
This may be due to the tableting force of 25 kN in the case of ExMan-A tablets being 
sufficiently high enough so that the granular material is crushed and forms strong 
bonds. Additionally, the porosity is also lower, meaning that fewer pores also exist. 
Water influx into the tablet occurs only in the limited weaker points in the tablet so 
the tablet disintegration leads to the release of larger fragments. 
6.5 Conclusion 
By using a particle imaging method more quantifiable information regarding 
the mechanisms of disintegration, including tablet swelling and particle release, was 
gained. The excipients of a tablet, particularly the filler which constitutes the bulk of 
the formulation, drastically affect the disintegration behaviour. Swelling is observed 
with the presence of MCC in the tablet formulation; the degree of swelling is 
directly dependent on the percentage of MCC. The ExMCC-A tablet formulation 
reached a higher maximum tablet area, whereas the ExMan-A tablets swelled but to 
a lower extent. The particle release rates were found to be almost identical, but 
ExMCC-A tablets released larger particles overall. 
The processing parameters used to produce tablets also play a part in how a 
tablet will erode. It is important to consider the first stress applied during RC and 
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the second stress which occurs during tableting. It was found that the swelling and 
disintegration trends were comparable for the tablets made using granules 
produced at 20 and 50 bar using both the USP method and the Flow Cell method, 
due to the tablets having almost equivalent porosities. However, by using the Flow 
Cell method it was possible to differentiate between the particle release rates for the 
two conditions. In brief, it was determined that the granule size distribution 
influences the particle release rate and it was reinforced that the porosity of a tablet 
influences the disintegration behaviour in terms of tablet swelling and erosion, 
however there are many other factors which also have an influence.  
In the case of the tablets made using 15 or 25 kN tableting force, a greater 
increase in tablet area and slower tablet erosion was observed for the latter tablet, 
which indicates a relaxation phenomenon occurrence. A slower rate of particle 
release was also detected for tablets compressed at 25 kN, and overall a lower 
number of total particles released was observed. This suggests that the slower rate 
of release combined with the slower disintegration of the tablet leads to the soluble 
material in the tablet, mainly mannitol, dissolving into solution before being 
detected by the imaging method.  
Overall it was established that the particle release is highly dependent on the 
processing conditions used to produce the tablet. The particle release is dependent 
on whether the granular material is crushed during tableting, and to what extent. 
Additionally, whether or not the stress applied during tableting causes strong 
bonding within the tablet also affects the size of the particles released. 
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Chapter 7. Conclusions 
and Future Work 
7.1 Conclusions 
This research set out to determine the effect of variation in the formulation 
and processing parameters on the tablet properties, namely the tablet compactibility 
and the tablet disintegration/dissolution behaviour. 
This study showed that the compactibility of a tablet is dependent on the two 
main stresses used during the production of a tablet; the roller compaction stress 
and the tableting stress. The roller compaction stress used during granulation 
determines the granular porosity. If the tableting stress applied to the granules is 
higher than the stress applied during granulation, then the granular material has the 
potential to be partially crushed. If the tableting stress is significantly higher than 
the RC stress, then the granular material more of the granule is crushed and also 
forms strong particle-particle bonds within the tablet. In literature this is termed as a 
“loss in compressibility”, which suggests that the material loses the ability to form 
strong tablets following high granulation stress. However, this is not the case; a 
more highly roller compacted granule requires a higher tableting stress to produce 
tablets of the same strength as a less compacted granule. By using X-ray 
tomography and compactibility studies it was confirmed that the granular integrity 
within the tablet varied depending on the RC and tableting stresses used. In terms 
of the material, MCC was found to produce the strongest tablets in every case. 
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Three different analysis methods were employed to determine the tablet 
disintegration behaviour. The LIXELL, Flow Cell and USP analysis methods were 
used to compare the disintegration behaviour for binary mixtures and placebo 
formulations, which were produced using varying granulation and tableting 
stresses. Two imaging techniques were compared to the standard USP method. This 
was done to determine which disintegration analysis method is able to provide 
more useful, quantifiable information to better understand the disintegration 
process. Additionally, 1H NMR was used in conjunction with the LIXELL analysis as 
a method of monitoring mannitol dissolution.  
The LIXELL method was able to detect differences in the cumulative particle 
release depending on the tablet formulation. But due to the nature of the LIXELL 
measurement being semi on-line, i.e. the detection occurs away from the 
disintegrating tablet, the data was too scattered to confirm with any certainty the 
validity of the results which were obtained. Additionally, it must be considered that 
the LIXELL technique subjects the tablet to mechanical stress due to the paddle 
stirrer. This may affect the results as a level of inaccuracy is introduced.  
The 1H NMR analysis was successfully able to determine the mannitol 
concentration in solution with time. It was found that a higher tableting stress used 
led to slower mannitol dissolution. However, the technique was found to be 
inherently inaccurate due to the method being off-line. It has to be considered that 
the concentration which was calculated included both the dissolved and 
undissolved mannitol as the undissolved mannitol had time to enter into solution. 
The USP method was able to distinguish different disintegration times when 
the formulation was varied, where tablets containing a higher percentage of MCC 
disintegrated more slowly. However, when the formulation containing an excess of 
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mannitol was analysed, the change in granulation and tableting parameters did not 
affect the disintegration times as distinctly. 
It was found that the Flow Cell method was able to detect changes in the 
disintegration behaviour when the processing parameters and formulation were 
altered, whereas the USP method was not. As the Flow Cell is an on-line imaging 
approach no information is lost, and it is possible to detect the change in tablet area 
as well as the particle release. Whereas the USP method was not able to detect these 
variations and determined that changes in the processing parameters had no effect 
on the disintegration time. Therefore it was confirmed that the Flow Cell is a more 
viable method in tablet disintegration analysis.  
To conclude, it was possible to visualise tablet disintegration using two 
different imagining analysis methods, but a more on-line method was found to be 
more precise. This meant that additional information was available which adds to 
the understanding of the processes occurring during disintegration, in terms of the 
particle release and tablet area, are affected by changes in the tablet formulation and 
processing parameters. This knowledge will allow for better and more efficient 
tablet design. 
7.2 Future Work 
From this research it was found that the Flow Cell is a viable on-line method 
for the analysis of pharmaceutical tablet disintegration, which is capable of 
distinguishing the effect of changes in processing parameters. The addition of a 
Refractive Index probe to the Flow Cell method will allow for the simultaneous 
examination of tablet disintegration as well as dissolution. Changes in the refractive 
index occur due to the dissolution of a soluble component, which in turn changes 
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the density of the dissolution medium. Unlike conductivity meters which can only 
detect ionic components, the refractive index is able to detect any soluble materials 
as they dissolve in real-time. 
This study has found that the stresses applied to a material affect the tablet 
disintegration in various ways. It would be useful to link the mechanical properties 
of the materials to the tablet compactibility and disintegration behaviour observed 
using the imaging methods.  
Higher resolution X-ray, such as synchrotron, measurements also need to be 
carried out to quantify the particle size distribution which exists within a tablet 
depending on the processing parameters used. A higher stress applied during 
tableting is expected to cause smaller particles to be present within the tablet if a 
low RC pressure granule is present. Additionally, the granular structure needs to be 
examined to monitor the granular porosity and the intra-granular tablet porosity 
with increasing tableting stress, with the tableting stress significantly surpassing the 
stress applied to the material during roller compaction. This will provide insight 
into the granule breakage which occurs during tableting, and it can also be 
determined whether the “loss in compressibility” is able to be overcome with 
sufficient tableting stress.   
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Appendix 
Appendix 1 Particle size distributions with time for Man100:MCC0 tablets produced 
using 20 bar RC pressure and 5 kN tableting force. 
 
Appendix 2 Particle size distributions with time for Man100:MCC0 tablets produced 
using 100 bar RC pressure and 5 kN tableting force. 
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Appendix 3 Particle size distributions with time for Man100:MCC0 tablets produced 
using 20 bar RC pressure and 20 kN tableting force. 
 
 
Appendix 4 Particle size distributions with time for Man100:MCC0 tablets produced 
using 100 bar RC pressure and 20 kN tableting force. 
 
0
256
4660
1
2
3
4
5
6
7
8
8
1
3
2
0
2
9
4
3
6
3
9
4
1
3
8
2
0
4
3
0
0
4
4
3
6
5
3
9
6
4
1
,4
2
2
2
,0
9
7
3
,0
9
4
Time (sec) 
q
0
 (
x)
 
xg (μm) 
0
207
4170
1
2
3
4
5
6
7
8
8
1
3
2
0
2
9
4
3
6
3
9
4
1
3
8
2
0
4
3
0
0
4
4
3
6
5
3
9
6
4
1
,4
2
2
2
,0
9
7
3
,0
9
4
Time (sec) 
q
0
 (
x)
 
xg (μm) 
Appendix 
173 
 
Appendix 5 Particle size distributions with time for Man75:MCC25 tablets produced 
using 20 bar RC pressure and 5 kN tableting force. 
 
 
Appendix 6 Particle size distributions with time for Man75:MCC25 tablets produced 
using 100 bar RC pressure and 5 kN tableting force. 
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Appendix 7 Particle size distributions with time for Man75:MCC25 tablets produced 
using 20 bar RC pressure and 20 kN tableting force. 
 
 
Appendix 8 Particle size distributions with time for Man75:MCC25 tablets produced 
using 100 bar RC pressure and 20 kN tableting force. 
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Appendix 9 Particle size distributions with time for Man25:MCC75 tablets produced 
using 20 bar RC pressure and 5 kN tableting force. 
 
 
Appendix 10 Particle size distributions with time for Man25:MCC75 tablets produced 
using 100 bar RC pressure and 5 kN tableting force. 
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Appendix 11 Particle size distributions with time for Man25:MCC75 tablets produced 
using 20 bar RC pressure and 20 kN tableting force. 
 
 
Appendix 12 Particle size distributions with time for Man25:MCC75 tablets produced 
using 100 bar RC pressure and 20 kN tableting force. 
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Appendix 13 Particle size distributions with time for Man0:MCC10 tablets produced 
using 20 bar RC pressure and 5 kN tableting force. 
 
 
Appendix 14 Particle size distributions with time for Man0:MCC10 tablets produced 
using 100 bar RC pressure and 5 kN tableting force. 
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Appendix 15 Particle size distributions with time for Man0:MCC10 tablets produced 
using 20 bar RC pressure and 20 kN tableting force. 
 
 
Appendix 16 Particle size distributions with time for Man0:MCC10 tablets produced 
using 100 bar RC pressure and 20 kN tableting force. 
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Appendix 17 Indication of the volume of solid in solution during the LIXELL 
measurement, determined using the D50 values and the number of particles released. 
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Appendix 18 MATLAB code developed by Xavier Mesnier, adapted for the project. 
(Mesnier et al., 2013) 
clear all, close all; 
  
%% 
  
tic 
  
pixelspermm=280;%  
sum_particles=0; 
  
files = dir('*.JPG'); 
  
for i = 1:numel(files) 
  
I=imread(files(i).name); 
  
% 
  
%%  
  
I2 = .2989*I(:,:,1)... 
    +.5870*I(:,:,2)... 
    +.1140*I(:,:,3); 
  
%%  
I_imadjust = imadjust(I2); 
  
%%  
%level = graythresh(I_imadjust); 
bw = im2bw(I_imadjust,0.34); %  
%%  
  
% ic = bwareaopen(bw,100); %%  
  
% %  
ic2 = imfill(ic,'holes'); 
  
  
%%  
  
[labeled,numObjects] = bwlabel(ic2,8); % 8 
  
numpart=numObjects; % 
  
RGB_label = label2rgb(labeled, @bone, 'b', 'shuffle'); % 
  
  
%%  
sum_particles=sum_particles+numpart; 
  
%%  
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particlesdata = regionprops(labeled,'area'); %'FilledArea', 
'centroid','Perimeter' 
  
allparticles = [particlesdata.Area]; 
  
  
max_area= max(allparticles); %  
  
  
realparticles=find(allparticles<max_area); % 
arearp=[particlesdata(realparticles).Area]; 
  
% Mean_areas_particles=mean(arearp); 
     
% areas_m=allparticles./(pixelspermm*pixelspermm); 
max_area_m=max_area./(pixelspermm*pixelspermm); 
particles_area_m=arearp./(pixelspermm*pixelspermm); 
Mean_areas_particles_m=Mean_areas_particles./(pixelspermm*pixelspermm)
; 
  
%%  
  
I3=bwboundaries(labeled); 
  
for x=1:length(I3); % 
    A(x,1)=length(I3{x,1}); 
end 
  
B=max(A(:,1)); % 
  
for x=1:length(I3); 
    A(x,1)=length(I3{x,1}); 
     
    if A(x,1)==B; %  
        I4=I3{x,1}; 
    end 
  
end 
  
%%  
  
% 
z=length(I4); 
k=1; 
l=1; 
  
minx=min(I4(:,2)); 
maxx=max(I4(:,2)); 
meanx=(minx+maxx)/2; %  
%  
%  
for x=1:z 
    if I4(x,2)<=meanx 
        I6(k,1)=I4(x,1); I6(k,2)=I4(x,2); 
        k=k+1; 
    else I7(l,1)=I4(x,1); I7(l,2)=I4(x,2); 
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        l=l+1;         
    end 
end 
  
%  
  
%% 
  
binsize=10; 
bin=3300/binsize; % 
  
jbin=zeros(bin,1); % 
  
           %  
for m=1:length(I6); 
    for j=1:bin; 
        if I6(m,1)>=(j-1)*binsize && I6(m,1)<j*binsize; 
            jbin(j,1)=jbin(j,1)+1; 
        end  
    end 
end 
  
  
  
        %  
        %  
        %  
flag=0; 
  
for p=1:bin 
    if flag==0; 
        if jbin(p,1)~=0; 
        jleft=p; 
        flag=1; 
        end 
    else flag=1; 
        if jbin(p,1)==0; 
        jright=p; 
        flag=2; 
        end 
    end    
end 
  
jcentre=(jright+jleft)/2; 
jcentre1=round(jcentre); 
  
       % 
  
% 
%  
% 
  
Difjbin=diff(jbin); 
  
diffjbin=single(Difjbin); % 
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%  
bsup=100; 
binf=-100; 
  
drapeau=0; 
  
for w=jcentre1:-1:jleft 
    if drapeau==0; 
        if diffjbin(w)>=bsup || diffjbin(w)<=binf; 
           ym=w; 
           drapeau=1; 
        end    
    end 
end 
  
 ymin=ym*binsize; 
  
 bandera=0; 
  
 for q=jcentre1:1:jright 
    if bandera==0; 
        if diffjbin(q)>=bsup || diffjbin(w)<=binf; 
           ymx=q; 
           bandera=1; 
        end    
    end 
end 
  
 ymax=ymx*binsize; 
  
 n=1; 
   
for r=1:length(I6) 
    if I6(r,1)>=ymin && I6(r,1)<=ymax; 
        I8(n,1)=I6(r,1); I8(n,2)=I6(r,2); 
        n=n+1; 
    end 
end 
  
meanleft=mean(I8(:,2)); 
  
%%  
  
binsize1=10; 
bin1=3300/binsize1; 
  
jbin1=zeros(bin1,1); % 
  
           %  
for a=1:length(I7); 
    for j=1:bin1; 
        if I7(a,1)>=(j-1)*binsize1 && I7(a,1)<j*binsize1; 
            jbin1(j,1)=jbin1(j,1)+1; 
        end  
    end 
end 
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flag1=0; 
  
for d=1:bin1 
    if flag1==0; 
        if jbin1(d,1)~=0; 
        jleft1=d; 
        flag1=1; 
        end 
    else flag1=1; 
        if jbin1(d,1)==0; 
        jright1=d; 
        flag1=2; 
        end 
    end    
end 
  
jcentre1=(jright1+jleft1)/2; 
jcentre11=round(jcentre1); 
  
       %  
  
Difjbin1=diff(jbin1); 
diffjbin1=single(Difjbin1); 
  
  
bsup1=100; 
binf1=-100; 
  
drapeau1=0; 
  
for b=jcentre11:-1:jleft1 
    if drapeau1==0; 
        if diffjbin1(b)>=bsup1 || diffjbin1(b)<=binf1; 
           ymr=b; 
           drapeau1=1; 
        end    
    end 
end 
  
 yminr=ymr*binsize1; 
  
  
 bandera1=0; 
  
 for c=jcentre11:1:jright1 
    if bandera1==0; 
        if diffjbin1(c)>=bsup || diffjbin1(c)<=binf; 
           ymrx=c; 
           bandera1=1; 
        end    
    end 
 end 
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 ymaxr=ymrx*binsize1; 
  
 e=1; 
   
for f=1:length(I7) 
    if I7(f,1)>=yminr && I7(f,1)<=ymaxr; 
        I9(e,1)=I7(f,1); I9(e,2)=I7(f,2); 
        e=e+1; 
    end 
end 
  
meanright=mean(I9(:,2)); 
  
width=meanright-meanleft; 
  
  
  
%%  
  
% 
z=length(I4); 
k=1; 
l=1; 
  
miny=min(I4(:,1)); 
maxy=max(I4(:,1)); 
meany=(miny+maxy)/2; 
  
  
%  
%  
  
  
  
for x=1:z 
    if I4(x,1)<=meany % 
        I16(k,1)=I4(x,1); I16(k,2)=I4(x,2); 
        k=k+1; 
    else I17(l,1)=I4(x,1); I17(l,2)=I4(x,2); 
        l=l+1;         
    end 
end 
  
  
  
%%  
  
binsizeB=10; 
binB=5000/binsizeB;  
  
jbinB=zeros(binB,1); % 
  
           %  
for m=1:length(I16); 
    for j=1:binB; 
        if I16(m,2)>=(j-1)*binsizeB && I16(m,2)<j*binsizeB; 
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            jbinB(j,1)=jbinB(j,1)+1; 
        end  
    end 
end 
  
  
  
        %  
        %  
        %  
flagB=0; 
  
for p=1:binB 
    if flagB==0; 
        if jbinB(p,1)~=0; 
        jleftB=p; 
        flagB=1; 
        end 
    end 
end 
  
for p=jleftB:binB   
    if flagB==1; 
        if jbinB(p,1)==0; 
        jrightB=p; 
        flagB=2; 
        end 
    end    
end 
  
jcentreB=(jrightB+jleftB)/2; 
jcentre1B=round(jcentreB); 
  
  
DifjbinB=diff(jbinB); 
  
diffjbinB=single(DifjbinB); 
bsupB=75; 
binfB=-75; 
  
drapeauB=0; 
  
for w=jcentre1B:-1:jleftB 
    if drapeauB==0; 
        if diffjbinB(w)>=bsupB || diffjbinB(w)<=binfB; 
           xm=w; 
           drapeauB=1; 
        end    
    end 
end 
  
 xminB=xm*binsizeB; 
  
  
 banderaB=0; 
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for q=jcentre1B:1:jrightB 
    if banderaB==0; 
        if diffjbinB(q)>=bsupB || diffjbinB(w)<=binfB; 
           xmx=q; 
           banderaB=1; 
        end  
    end 
end 
  
 xmaxB=xmx*binsizeB; 
  
 m=1; 
   
for r=1:length(I16) 
    if I16(r,2)>=xminB && I16(r,2)<=xmaxB; 
        I18(m,1)=I16(r,1); I18(m,2)=I16(r,2); 
        m=m+1; 
    end 
end 
  
meanbottom=mean(I18(:,1)); 
  
%%  
  
binsize1B=10; 
bin1B=5000/binsize1B; 
  
jbin1B=zeros(bin1B,1); % 
  
           % for a=1:length(I17); 
    for j=1:bin1B; 
        if I17(a,2)>=(j-1)*binsize1B && I17(a,2)<j*binsize1B; 
            jbin1B(j,1)=jbin1B(j,1)+1; 
        end  
    end 
end 
  
         
flag1B=0; 
  
for d=1:bin1B 
    if flag1B==0; 
        if jbin1B(d,1)~=0; 
        jleft1B=d; 
        flag1B=1; 
        end 
    end 
end     
  
for d=jleft1B:bin1B 
    if flag1B==1; 
        if jbin1B(d,1)==0; 
        jright1B=d; 
        flag1B=2; 
        end 
    end    
end 
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jcentre1B=(jright1B+jleft1B)/2; 
jcentre11B=round(jcentre1B); 
  
        
  
  
Difjbin1B=diff(jbin1B); 
diffjbin1B=single(Difjbin1B); 
  
  
bsup1B=100; 
binf1B=-100; 
  
drapeau1B=0; 
  
for b=jcentre11B:-1:jleft1B 
    if drapeau1B==0; 
        if diffjbin1B(b)>=bsup1B || diffjbin1B(b)<=binf1B; 
           xmb=b; 
           drapeau1B=1; 
        end    
    end 
end 
  
 xminbB=xmb*binsize1B; 
  
  
 bandera1B=0; 
  
 for c=jcentre11B:1:jright1B 
    if bandera1B==0; 
        if diffjbin1B(c)>=bsup1B || diffjbin1B(c)<=binf1B; 
           xmbx=c; 
           bandera1B=1; 
        end    
    end 
end 
  
 xmaxbB=xmbx*binsize1B; 
  
 e=1; 
   
for f=1:length(I17) 
    if I17(f,2)>=xminbB && I17(f,2)<=xmaxbB; 
        I19(e,1)=I17(f,1); I19(e,2)=I17(f,2); 
        e=e+1; 
    end 
end 
  
meantop=mean(I19(:,1)); 
  
thickness=meantop-meanbottom; 
  
%% write 
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widthmm=width/pixelspermm; 
thicknessmm=thickness/pixelspermm; 
  
dlmwrite('output_area.csv', areas_m, '-append','newline','pc'); 
  
dlmwrite('output_maxarea.csv', max_area_m, '-append','newline','pc') 
  
dlmwrite('output_partarea.csv',particles_area_m , '-
append','newline','pc') 
  
  
dlmwrite('output_numparticles.csv', numpart, '-append','newline','pc') 
  
dlmwrite('output_sumparticle.csv', sum_particles, '-
append','newline','pc') 
  
  
dlmwrite('output_thickness.csv', thickness, '-append','newline','pc'); 
  
dlmwrite('output_width.csv', width, '-append','newline','pc'); 
  
dlmwrite('output_toc.csv', toc, '-append','newline','pc'); 
  
%% 
  
% 
  
figure 
  
subplot(3,3,1), imshow(I),title('Raw 
Image','FontWeight','bold','FontSize',8); 
subplot(3,3,2), 
imshow(bw),title('Objects','FontWeight','bold','FontSize',8); 
subplot(3,3,3), 
imshow(RGB_label),title('Objects','FontWeight','bold','FontSize',8); 
  
subplot(3,3,4), plot(I4(:,1),I4(:,2)),title('tablet 
contour','FontWeight','bold','FontSize',8); 
  
subplot(3,3,5), plot(I8(:,1),I8(:,2)),title('left 
part','FontWeight','bold','FontSize',8); 
subplot(3,3,6), plot(I9(:,1),I9(:,2)),title('right 
part','FontWeight','bold','FontSize',8); 
  
subplot(3,3,7), plot(I18(:,1),I18(:,2)),title('top 
part','FontWeight','bold','FontSize',8); 
subplot(3,3,8), plot(I19(:,1),I19(:,2)),title('bottom 
part','FontWeight','bold','FontSize',8); 
  
filename = sprintf(files(i).name,i); 
  
print('-dtiff',['analy' filename]); 
  
close all; 
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Appendix 19 Image obtained during the Flow Cell analysis for Man0:MCC100 tablets 
produced using 20 bar RC pressure and 5 kN tableting force. 
  
 
 
 
 
 
 
 
 
toc 
  
end 
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Appendix 20 MATLAB code developed by Kimiaki Washino and Daniel Stevenson to 
determine the particle size distribution of the released particles during Flow Cell 
analysis. 
% Distribution calculator 
  
clear all, close all; 
  
%----------------- Input parameters begin -----------------% 
interactive = input('use interactive mode? true or false\n'); 
  
% Frame rate (input parameter) 
frameRate = 1/12; 
if interactive == true 
    frameRate = input('frame rate\n'); 
end 
  
% Time interval (input parameter) 
timeInterval = 60; 
if interactive == true 
    timeInterval = input('time interval\n'); 
end 
  
% Bin size 
binSize = 10; 
if interactive == true 
    binSize = input('bin size\n'); 
end 
  
% Input file name (input parameter) 
inputFile = 'output_partarea.csv'; 
if interactive == true 
    inputFile = input('input file name (make sure that the name is enclosed 
in single quatation marks)\n'); 
end 
M = csvread(inputFile); 
  
% Set range 
minMf = 0; 
maxMf = 1e-1; 
if interactive == true 
    minMf = input('minimum value = '); 
    maxMf = input('maxumum value = '); 
end 
%----------------- Input parameters end -----------------% 
  
delete('out/out*.csv'); 
SMALL = 1e-15; 
nRows = size(M, 1); 
nColumns = size(M, 2); 
  
processEveryColumns = round(timeInterval * frameRate); 
if abs(processEveryColumns - timeInterval * frameRate) > SMALL 
    error('frame rate and time interval parameters do not match'); 
end 
  
minM = minMf; 
maxM = maxMf; 
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dBin = (maxM - minM) / binSize; 
  
x = [minM + 0.5*dBin : dBin : maxM - 0.5*dBin]; 
  
i = 1; 
n = 1; 
while i < nRows 
    % Data initialisation at the new time interval 
    if mod(i-1, processEveryColumns) == 0 
        y = 0*x; 
    end 
     
    % Count the number of the particles in each bin 
    for j = 1 : nColumns 
        for k = 1 : binSize-1 
            if M(i,j) > SMALL 
                if M(i,j) >= x(k) - 0.5*dBin && M(i,j) < x(k) + 0.5*dBin 
                    y(k) = y(k) + 1; 
                end 
            end 
        end 
        if M(i,j) >= x(end) + 0.5*dBin 
            y(end) = y(end) + 1; 
        end 
    end 
     
    % Finalise the data at the end of the time interval 
    if mod(i, processEveryColumns) == 0 
        figure(1); 
        plot(x,y) 
        xlabel('Area [mm^2]'); 
        ylabel('Number of particles [-]'); 
        drawnow 
         
        MV(n) = getframe(gcf); 
         
        outData = [x', y']; 
         
        % Output file is stored in the folder called 'out' 
        if ~exist('out', 'dir') 
            mkdir('out') 
        end 
         
        outName = sprintf('out/out%d.csv', i/frameRate); 
        csvwrite(outName, outData); 
         
        n = n + 1; 
    end 
     
    i = i + 1; 
end 
  
% Create movie 
movie2avi(MV, './movie', 'compression', 'None', 'fps', 20, 'quality', 100) 
